BannerInterno

Meet the speakers


Diana Alecsandru
DIANA ALECSANDRU
Current Job:
Dr. Diana Alecsandru, MD, PhD is an attending physician at IVI RMA Madrid where she serves as Consultant Clinical Immunologist Physician for Reproductive Immunology. She is Assistant Professor at Complutense University in the Department of Microbiology, Division of Immunology, and Professor of Master Degree in Human Reproduction at Rey Juan Carlos University, Complutense University and European University-Madrid.Spain. She participates as Speaker in The Annual In Vitro Fertilization and Embryo Transfer, UC San Diego School of Medicine.
Education & Training:
She received her medical degree from Carol Davila University Medical School Bucharest. Romania. She completed her residency training in Clinical Immunology in San Carlos Hospital, La Paz Hospital and Gregorio Marañon Hospital in Madrid, Spain and received her Immunology Certification from Education and Health Ministry of Spain. She completed her PhD in Medicine at Complutense University, focused in immunogenetic and her work has awarded with the Extraordinary PhD Award in Medicine Section at Complutense University –Madrid, Spain. Dr. Alecsandru complete her Clinical Immunology fellowship training at Immunology Department of Royal Free Hospital. Jeffrey Modell Foundation. London. UK. Dr. Alecsandru complete her Reproductive Immunology training in Gregorio Marañon Hospital Madrid in the FIS –Carlos III Health Institute (Spain) program.
Research Activity:
Her research interests include early placentation, recurrent implantation failure, recurrent miscarriage, immuno-genetic and immunological factors involved in embryo implantation, autoimmunity impact in ART outcome, metabolic status effect on ART success. Dr. Alecsandru is a board certified Clinical Immunologist, board certified Reproductive Immunology. He is active in the Spanish College of Medicine. Dr. Alecsandru has been invited to speak nationally and internationally and has authored and contributed to over 50 peer reviewed publications, published chapters and abstracts. She is author of several textbooks on recurrent implantation failure. She serves on the Editorial Board for Obstetrics & Gynecology International Journal (OGIJ). She serves as Global Fertility and Sterility Associate. Fertility and Sterility USA. She also serves as Ad Hoc Reviewer for Human Reproduction, Fertility and Sterility, Reproductive BioMedicine Online. She is researcher of projects funded by the Ministries of Education and Health in Spain.
Honors & Recognitions:
• Extraordinary PhD Award in Medicine Section at Complutense University.Madrid, Spain
• Member of European Society for Human Reproduction and Embryology (ESHRE), European Society of Reproductive Immunology (ESRI), Spanish Fertility Society (SEF), Spanish Immunology Society (SEI).

Baris Ata

Chris Barratt

Christina Bergh

Curriculum vitae Christina Bergh     

PhD  1993, Göteborg University, Sweden

Specialist in Obstetrics and Gynecology 1985

Current position

2009-09-01-                        Professor Obstetrics and Gynecology with focus on Evidence Based Medicine, Inst of Clinical Sciences, Sahlgrenska Academy, Göteborg University, Sweden

2007-10-01-                Head of the Health Technology Assessment unit, Västra Götaland

2007-01-01-                        Head of the National Quality Registry of Assisted Reproduction in Sweden

Opponent for PhD examinations: Six times 2001-2021

Previous PhD

Main supervisor:11 theses, co-supervisor: three theses

Present PhD

4 PhD doctors

Main research area: Quality and safety in assisted reproduction technology

Single embryo transfer, Children follow up after ART, Embryo selection, Frozen/thawed embryo cycles, Quality of care

Invited lectures at around 70 international congresses

Current Research funding

1.0 million SEK/year (Safety and Quality in ART)

Research publications: 171 original publications, 34 reviews and 50 debates, book chapters or others. H-index: 67 (Google Scholar)

Rossella Cannarella

Rossella Cannarella

Current Job:

  • Rossella Cannarella, MD, PhD is an Endocrinologist and a Researcher currently attending the Glickman Urological & Kidney Institute at the Cleveland Clinic (Cleveland, OH, USA). She serves as a Professor for the Master of Clinical Embriology and Seminological Andrology, at the Department of Biology, University of Catania (Catania, Italy).

 

Education & Training:

  • She received her medical degree from the University of Catania (Catania, Italy) in 2014. She completed her residency training in the European Academy of Andrology (EAA) Training Center of Catania in 2019. She has been a Visiting Researcher at the University of Massachusetts Medical School (Worcester, MA, USA) in 2021-2022, where she studied the impact of sperm epigenetics on mice embryo development. She earned her International PhD in Translational Biomedicine at the University of Catania, in 2022.

 

Research Activity:

  • Her research interests include male infertility, sperm epigenetics, male hypogonadism, genetics in andrology, testicular function in childhood. Dr. Cannarella is a board certified EAA Clinical Andrologist. She has been invited to speak in more than 30 national and international meetings, and has authored and contributed to over 160 peer reviewed publications, 5 book chapters and 29 abstracts. She serves on the Editorial Board for Frontiers in Endocrinology, section Reproduction, Minerva Endocrinology and BMC Urology. She also serves as Ad Hoc Reviewer for Fertility and Sterility, Reproductive BioMedicine Online, Human Genetics and others. She serves the Italian Society of Andrology and Sexual Medicine (SIAMS) as a member of the ART and sperm bank Committee.

 

Honors & Recognitions:

2020: Winner of the ESHRE Travelling Fellowship, European Society of Human Reproduction and Embryology, for the project: “Role of sperm-carried growth factors in embryogenesis: Possible diagnostic targets?

Jacky Boivin

Ernesto Bosch
Ernesto Bosch, M.D., Ph.D.
Medical Director of the Human Reproduction Unit of the Instituto Valenciano de Infertilidad.  University of Valencia. Spain
Ernesto Bosch was born in Philadelphia, USA, in 1968. He completed Medicine School at the University of Valencia in 1992 and from 1993 to 1997, did his Residency in Obstetrics and Gynaecology at Hospital La Fe, Valencia.   Ernesto trained in Human Reproduction at the Hospital of the University of Pennsylvania in 1997; and in 1999, he completed his doctoral thesis on the influence of LH in oocyte quality, with “cum laude” qualification, at the University of Valencia.  In January 2000, Ernesto joined the team at the Human Reproduction Unit of the Instituto Valenciano de Infertilidad in Valencia, Spain; in 2008 he obtained the title of Master in Research on Health Sciences, by the Autonomous University if Barcelona.  Dr. Bosch has published 62 papers in peer reviewed journals and written more than 50 book chapters in the field of IVF; has given over 250 lectures at international meetings around the world; He belongs to the Editorial Board of Fertility & Sterility, and Reproductive Biomedicine Online and is a regular reviewer for Human Reproduction, and Reproductive Biology and Endocrinology among others. He received the Scientific Program Prize Paper Award at the 2008 Annual Meeting of the American Society for Reproductive Medicine.   Belonged to the Special Interest Group on Reproductive Endocrinology of the Spanish Fertility Society, and currently to the Special Interest Group on Reproductive Endocrinology of ESHRE. He was the National Representative of the Spanish clinicians at the ESHRE committee between 2014 and 2016. In May 2010, Dr. Bosch was appointed Medical Director of the Human Reproduction Unit of the Instituto Valenciano de Infertilidad in Valencia. 
In 2018 he has obtained an MBA on Healthcare Management by the IMF Business School and University Camilo José Cela from Madrid.

PERSONAL DATA

 

NAME: Ernesto Bosch Aparicio

BIRTHDATE: March, 9th, 1968

BIRTHPLACE: Philadelphia (PA), USA.

CURRENT WORKPLACE: Instituto Valenciano de Infertilidad. (IVI)

Plaza Policía Local, 3. 46015. Valencia. SPAIN.

Pone: +34 96 305 00 00

FAX: +34 96 305 09 00

e-mail: Esta dirección de correo electrónico está siendo protegida contra los robots de spam. Necesita tener JavaScript habilitado para poder verlo.

ACADEMIC

  • 1992: Licensed from Medical School. University of Valencia.
  • 1993: General PhysicianHospital Clínico Universitario. Valencia.
  • 1994-97: Residency on Obstetrics & Gynaecology. Hospital Universitario La Fe. Valencia.
  • 1995-96: Doctoral Courses. University of Valencia.
  • 1997: Clinical Fellowship on Human Reproduction at The Hospital of the University of Pennsylvania. Philadelphia. USA.
  • 1998: Staff at the Human Reproduction unit. Hospital Universitario La Fe. Valencia.
  • 1999: Postdoctoral Research Project: “Influence of intrafollicular LH on oocyte quality in In Vitro Fertilization” qualified with Excellent “cum laude” at the University of Valencia, under the direction of Prof. Alberto Romeu from Hospital Universitario La Fe of Valencia, and Prof. Luis Blasco from The Hospital of The University of Pennsylvania, Philadelphia, USA.
  • 2000-2009: Gynaecologist of The Human Reproduction Unit at The Instituto Valenciano de Infertilidad, Valencia. Spain.
  • 2010….Director of the Human Reproduction Unit at The Instituto Valenciano de Infertilidad, Valencia, Spain. 

OTHER COURSES-PRICES

 

  • 1997-98:  Statistical Methods in Health Sciences. (300 hours). Universidad Autónoma de Barcelona.
  • 1999-2000: Multivariate Analysis. (240 hours). Universidad Autónoma de Barcelona.
  • 2003: European Diplomat in Gynecological Endoscopy. Universidad de Alcalá de Henares, and University of Clermont-Ferrand
  • 2008: Master on Design of Research projects. Universidad Autónoma de Barcelona.
  • 2008: ASRM General Program Paper Prize. 
  • 2018. MBA on Healthcare management. IMF Business School. Universidad Camilo José Cela. Madrid.

PUBLICATIONS INDEXED IN MEDLINE DATABASE (by publicaction date)

1: Bosch E, Havelock J, Martin FS, Rasmussen BB, Klein BM, Mannaerts B, Arce JC; ESTHER-2 Study Group. Follitropin delta in repeated ovarian stimulation for IVF: a controlled, assessor-blind Phase 3 safety trial. Reprod Biomed Online. 2018 Dec14. pii: S1472-6483(18)30605-9. doi: 10.1016/j.rbmo.2018.10.012. [Epub ahead of print].

2: Spanish Infertility SWOT Group (SISG), Checa MA, Bellver J, Bosch E, EspinósJJ, Fabregues F, Fontes J, García-Velasco J, Requena A. Hysteroscopic septumresection and reproductive medicine: A  SWOT analysis. Reprod Biomed Online. 2018 Dec;37(6):709-715. doi: 10.1016/j.rbmo.2018.09.013. Epub 2018 Oct 22. 

3: Bosch E, Bulletti C, Copperman AB, Fanchin R, Yarali H, Petta CA, Polyzos NP, Shapiro D, Ubaldi FM, Garcia Velasco JA, Longobardi S, D'Hooghe T, Humaidan P; Delphi TTP Consensus Group. How time to healthy singleton delivery could affect decision-making during infertility treatment: a Delphi consensus. Reprod Biomed Online. 2018 Nov 7. pii: S1472-6483(18)30526-1. doi: 10.1016/j.rbmo.2018.09.019. [Epub ahead of print] 

4: Labarta E, Marin D, Remohí J, Bosch E. Conventional versus minimal ovarian stimulation: an intra-patient comparison of ovarian response in poor-responder women according to Bologna Criteria. Reprod Biomed Online. 2018

Oct;37(4):434-441. doi: 10.1016/j.rbmo.2018.07.007. Epub 2018 Aug 23.

5: Polyzos NP, Drakopoulos P, Parra J, Pellicer A, Santos-Ribeiro S, Tournaye H, Bosch E, Garcia-Velasco J. Cumulative live birth rates according to the number of oocytes retrieved after the first ovarian stimulation for in vitro

fertilization/intracytoplasmic sperm injection: a multicenter multinational

analysis including 15,000 women. Fertil Steril. 2018 Sep;110(4):661-670.e1. doi: 10.1016/j.fertnstert.2018.04.039. 

6. Drakopoulos P, Santos-Ribeiro S, Bosch E, Garcia-Velasco J, Blockeel C, Romito A, Tournaye H, Polyzos N. The Effect of Dose Adjustments in a Subsequent Cycle of Women With Suboptimal Response Following Conventional Ovarian Stimulation . Front Endocrinol 2018; 9: 361. 

7: Alviggi C, Conforti A, Esteves SC, Andersen CY, Bosch E, Bühler K, Ferraretti AP, De Placido G, Mollo A, Fischer R, Humaidan P; International Collaborative Group for the Study of r-hLH (iCOS-LH). Recombinant luteinizing hormonesupplementation in assisted reproductive technology: a systematic review. Fertil Steril. 2018 Apr;109(4):644-664. 

8: Lawrenz B, Labarta E, Fatemi H, Bosch E. Premature progesterone elevation: targets and rescue strategies. Fertil Steril. 2018 Apr;109(4):577-582. 

9: La Marca A, Blockeel C, Bosch E, Fanchin R, Fatemi HM, Fauser BC,

García-Velasco JA, Humaidan P, Tarlatzis BC, Nelson SM. Individualized FSH dosing improves safety and reduces iatrogenic poor response while maintaining live-birth rates. Hum Reprod. 2018 May 1;33(5):982-983. 

10. Bosch E, Labarta E, Pellicer A. Does cumulative live birth plateau beyond a certain ovarian response? Fertil Steril. 2017 Dec;108(6):943

11. Labarta E, Mariani G, Holtmann N, Celada P, Remohí J, Bosch E. Low serum progesterone on the day of embryo transfer is associated with a diminished ongoing pregnancy rate in oocyte donation cycles after artificial endometrial preparation: a prospective study. Hum Reprod. 2017 Oct 13:1-6

12. Labarta E, Bosch E, Mercader A, Alamá P, Mateu E, Pellicer A. A Higher Ovarian Response after Stimulation for IVF Is Related to a Higher Number of Euploid Embryos. Biomed Res Int. 2017;2017:5637923. 

13. Nyboe Andersen A, Nelson SM, Fauser BC, García-Velasco JA, Klein BM, Arce JC;  ESTHER-1 study group. Individualized versus conventional ovarian stimulation for in vitro fertilization: a multicenter, randomized, controlled, assessor-blinded, phase 3 noninferiority trial. Fertil Steril. 2017 Feb;107(2):387-396.

14. Bosch E, Labarta E, Kolibianakis E, Rosen M, Meldrum D. Regimen of ovarian stimulation affects oocyte and therefore embryo quality. Fertil Steril. 2016. 

15. Garcia-Velasco JA, Bosch E. The necessity to define the sub-optimalresponders. Hum Reprod. 2015 Dec;30(12):2958. 

16. Martin J, Asan, Yi Y, Alberola T, Rodríguez-Iglesias B, Jiménez-Almazán J, Li Q, Du H, Alama P, Ruiz A, Bosch E, Garrido N, Simon C. Comprehensive carrier genetic test using next-generation deoxyribonucleic acid sequencing in infertile couples wishing to conceive through assisted reproductive technology. Fertil Steril. 2015 Nov;104(5):1286-93. 

17. Garrido N, Bosch E, Alamá P, Ruiz A. The time to prevent mendelian genetic diseases from donated or own gametes has come. Fertil Steril. 2015Oct;104(4):833-5. 

18. Bosch E, Nyboe Andersen A, Barri P, García-Velasco JA, de Sutter P,Fernández-Sánchez M, Visnova H, Klein BM, Mannaerts B, Arce JC. Follicular and endocrine dose-responses according to anti-Müllerian hormone levels in IVF patients treated with a novel human recombinant FSH (FE 999049). Clin Endocrinol (Oxf). 2015 Jul 23. doi: 10.1111/cen.12864. [Epub ahead of print] PubMed PMID:26202150.

19. Bosch E. High responders and patients with a good prognosis are not immune to the negative impact on live birth rate of elevated P on the day of triggering.Fertil Steril. 2015 Jun;103(6):1423. doi: 10.1016/j.fertnstert.2015.03.031. Epub   2015 May 5. PubMed PMID: 25956373.

20. Anderson RA, Anckaert E, Bosch E, Dewailly D, Dunlop CE, Fehr D, Nardo L, Smitz J, Tremellen K, Denk B, Geistanger A, Hund M. Prospective study into the value of the automated Elecsys antimüllerian hormone assay for the assessment of the ovarian growing follicle pool. Fertil Steril. 2015 Apr;103(4):1074-1080. 

21. Simón C, Bosch E, Bellver J. Reply: Endometrial scratching for women with repeated implantation failure. Hum Reprod. 2014 Oct 14.

22. Arce JC, Nyboe Andersen A, Fernández-Sánchez M, Visnova H, Bosch E,García-Velasco JA, Barri P, de Sutter P, Klein BM, Fauser BC. Ovarian response to recombinant human follicle-stimulating hormone: a randomized, anti-Müllerian hormone-stratified, dose-response trial in women undergoing in vitro fertilization/intracytoplasmic sperm injection. Fertil Steril. 2014 Sep 23[Epub ahead of print] 

23. Requena A, Cruz M, Bosch E, Meseguer M, García-Velasco JA. High progesterone levels in women with high ovarian response do not affect clinical outcomes: a retrospective cohort study. Reprod Biol Endocrinol. 2014 Jul 26;12:69. doi: 10.1186/1477-7827-12-69. PubMed PMID: 25064138; PubMed Central PMCID: PMC4118192.

24. Labarta E, Bosch E, Pellicer A. Impact of ovarian stimulation withgonadotrophins on embryo aneuploidy. Hum Reprod Update. 2014 Jul 10..[Epub ahead of print].

25. Bosch E. Comment on 'Recombinant LH supplementation to a standard GnRH antagonist protocol in women of 35 years old or older undergoing IVF/ICSI: a randomized controlled multicentre study'. Hum Reprod. 2014 Mar;29(3):636-7. 

26. Bosch E. Does progesterone elevation compromise pregnancy rates in high responders? Insufficient evidence to draw a conclusion. Fertil Steril. 2014Jan;101(1):e3-4. 

27. Nardo LG, Bosch E, Lambalk CB, Gelbaya TA. Controlled ovarian hyperstimulation regimens: a review of the available evidence for clinical practice. Produced on behalf of the BFS Policy and Practice Committee. Hum Fertil (Camb). 2013 Sep;16(3):144-50. 

28. Muñoz E, Taboas E, Portela S, Aguilar J, Fernandez I, Muñoz L, Bosch E.Treatment of luteal phase defects in assisted reproduction. Curr Drug Targets.2013 Jul;14(8):832-42. 

29. Rubio C, Bellver J, Rodrigo L, Bosch E, Mercader A, Vidal C, De Los Santos MJ, Giles J, Labarta E, Domingo J, Crespo J, Remohí J, Pellicer A, Simón C. Preimplantation genetic screening using fluorescence in situ hybridization in patients with repetitive implantation failure and advanced maternal age: two randomized trials. Fertil Steril. 2013 Apr;99(5):1400-7.

30. Choi B, Bosch E, Lannon BM, Leveille MC, Wong WH, Leader A, Pellicer A, Penzias AS, Yao MW. Personalized prediction of first-cycle in vitro fertilization success. Fertil Steril. 2013 Mar 20. doi:pii: S0015-0282(13)00273-2.10.1016/j.fertnstert.2013.02.016. [Epub ahead of print] PubMed PMID: 23522806.

31. De los Santos MJ, García-Laez V, Beltrán D, Labarta E, Zuzuarregui JL, Alamá P, Gámiz P, Crespo J, Bosch E, Pellicer A. The follicular hormonal profile in low-responder patients undergoing unstimulated cycles: is it hypoandrogenic? Hum  Reprod. 2013 Jan;28(1):224-9. doi: 10.1093/humrep/des349. Epub 2012 Sep 27. PubMed PMID: 23019297.

32. Labarta E, Bosch E, Alamá P, Rubio C, Rodrigo L, Pellicer A. Moderate ovarian stimulation does not increase the incidence of human embryo chromosomal abnormalities in in vitro fertilization cycles. J Clin Endocrinol Metab. 2012 Oct;97(10):E1987-94. doi: 10.1210/jc.2012-1738. Epub 2012 Aug 3. PubMed PMID: 22865900; PubMed Central PMCID: PMC3462940.

33. Bosch E. Can we skip weekends in GnRH antagonist cycles without compromising the final outcome? Fertil Steril. 2012 Jun;97(6):1299-300.

34. Muñoz E, Bosch E, Fernandez I, Portela S, Ortiz G, Remohi J, Pellicer A. The role of LH in ovarian stimulation. Curr Pharm Biotechnol. 2012 Mar;13(3):409-16.  Review. PubMed PMID: 21657991.

35. Nardo LG, Fleming R, Howles CM, Bosch E, Hamamah S, Ubaldi FM, Hugues JN, Balen AH, Nelson SM. Conventional ovarian stimulation no longer exists: welcome to the age of individualized ovarian stimulation. Reprod Biomed Online. 2011 Aug;23(2):141-8. doi: 10.1016/j.rbmo.2011.05.008. Epub 2011 May 19. PubMed PMID: 21665542.

36. Labarta E, Martínez-Conejero JA, Alamá P, Horcajadas JA, Pellicer A, Simón C,  Bosch E. Endometrial receptivity is affected in women with high circulating progesterone levels at the end of the follicular phase: a functional genomics analysis. Hum Reprod. 2011 Jul;26(7):1813-25.

37. Papanikolaou EG, Polyzos NP, Humaidan P, Pados G, Bosch E, Tournaye H, Tarlatzis B. Aromatase inhibitors in stimulated IVF cycles. Reprod Biol Endocrinol. 2011 Jun 21;9:85. doi: 10.1186/1477-7827-9-85. Review. PubMed PMID: 21693033; PubMed Central PMCID: PMC3150251.

38. Bosch E, Ezcurra D. Individualised controlled ovarian stimulation (iCOS):

maximising success rates for assisted reproductive technology patients. Reprod Biol Endocrinol. 2011 Jun 21;9:82. doi: 10.1186/1477-7827-9-82. PubMed PMID: 21693025; PubMed Central PMCID: PMC3150250.

39. Bosch E, Labarta E, Crespo J, Simón C, Remohí J, Pellicer A. Impact luteinizing hormone administration on gonadotropin-releasing hormone antagonist cycles: an age-adjusted analysis. Fertil Steril. 2011 Mar 1;95(3):1031-6. doi: 10.1016/j.fertnstert.2010.10.021. Epub 2010 Nov 10. PubMed PMID: 21067717.

40. Gabbanini M, Privitera L, Monzó A, Higueras G, Fuster S, Garrido N, Bosch E,  Pellicer A. The use of prediction models of spontaneous pregnancy in in vitro fertilization units reveals differences between the expected results of public and private clinics in Spain. Fertil Steril. 2010 Nov;94(6):2376-8. doi:10.1016/j.fertnstert.2010.02.038. Epub 2010 Mar 29. PubMed PMID: 20347077.

41. Bellver J, Labarta E, Bosch E, Melo MA, Vidal C, Remohí J, Pellicer A. GnRH agonist administration at the time of implantation does not improve pregnancy outcome in intrauterine insemination cycles: a randomized controlled trial. Fertil Steril. 2010 Aug;94(3):1065-71. 

42. Bosch E, Labarta E, Crespo J, Simón C, Remohí J, Jenkins J, Pellicer A.

Circulating progesterone levels and ongoing pregnancy rates in controlled ovarian stimulation cycles for in vitro fertilization: analysis of over 4000 cycles. Hum  Reprod. 2010 Aug;25(8):2092-100. 

43. Bosch E. Recombinant human follicular stimulating hormone and recombinant human luteinizing hormone in a 2:1 ratio combination. Pharmacological characteristics and clinical applications. Expert Opin Biol Ther. 2010 Jun;10(6):1001-9. doi: 10.1517/14712598.2010.485607. Review. PubMed 

44. Bosch E, Vidal C, Labarta E, Simon C, Remohi J, Pellicer A. Highly purified hMG versus recombinant FSH in ovarian hyperstimulation with GnRH antagonists—a randomized study. Hum Reprod. 2008 Oct;23(10):2346-51. 

45. Soares SR, Velasco JA, Fernandez M, Bosch E, Remohí J, Pellicer A, Simón C. Clinical factors affecting endometrial receptiveness in oocyte donation cycles. Fertil Steril. 2008 Mar;89(3):491.

46. Bosch E. Comment on: is progesterone elevation on the day of human chorionic  gonadotrophin administration associated with the probability of pregnancy in in vitro fertilization? A systematic review and meta-analysis. By Venetis et al (2007). Hum Reprod Update. 2008 Mar-Apr;14(2):194-5; author reply 195-6. doi: 10.1093/humupd/dmm046. Epub 2008 Jan 28. PubMed PMID: 18230603.

47. Bellver J, Melo MA, Bosch E, Serra V, Remohí J, Pellicer A. Obesity and poor   reproductive outcome: the potential role of the endometrium. Fertil Steril. 2007  Aug;88(2):446-51. Epub 2007 Apr 6. PubMed PMID: 17418840.

48. Cobo A, Bosch E, Alvarez C, de los Santos MJ, Pellicer A, Remohí J. Effect of a sharp serum oestradiol fall before HCG administration during ovarian stimulation in donors. Reprod Biomed Online. 2007 Aug;15(2):169-74. PubMed 

49. Escribá MJ, Bellver J, Bosch E, Sánchez M, Pellicer A, Remohí J. Delaying the initiation of progesterone supplementation until the day of fertilization does not compromise cycle outcome in patients receiving donated oocytes: a randomized  study. Fertil Steril. 2006 Jul;86(1):92-7.

50. Melo MA, Meseguer M, Garrido N, Bosch E, Pellicer A, Remohí J. The

significance of premature luteinization in an oocyte-donation programme. Hum Reprod. 2006 Jun;21(6):1503-7. 

51. Simon C, Oberyé J, Bellver J, Vidal C, Bosch E, Horcajadas JA, Murphy C, Adams S, Riesewijk A, Mannaerts B, Pellicer A. Similar endometrial development in oocyte donors treated with either high- or standard-dose GnRH antagonist compared to treatment with a GnRH agonist or in natural cycles. Hum Reprod. 2005 Dec;20(12):3318-27. 

52. Bellver J, Bosch E, Remohí J, Pellicer A. Evidence-based medicine is gaining   momentum. Fertil Steril. 2005 Nov;84(5):1555-6; author reply 1556-7.

53. Bosch E, Escudero E, Crespo J, Simón C, Remohí J, Pellicer A. Serum luteinizing hormone in patients undergoing ovarian stimulation withgonadotropin-releasing hormone antagonists and recombinant follicle-stimulating hormone and its relationship with cycle outcome. Fertil Steril. 2005 Nov;84(5):1529-32. 

54. Soares SR, Troncoso C, Bosch E, Serra V, Simón C, Remohí J, Pellicer A. Age and uterine receptiveness: predicting the outcome of oocyte donation cycles. J Clin Endocrinol Metab. 2005 Jul;90(7):4399-404. 

55. Christiansen OB, Nybo Andersen AM, Bosch E, Daya S, Delves PJ, Hviid TV, Kutteh WH, Laird SM, Li TC, van der Ven K. Evidence-based investigations and treatments of recurrent pregnancy loss. Fertil Steril. 2005 Apr;83(4):821-39. Review. PubMed PMID: 15820784.

56. Bellver J, Bosch E, Pellicer A. BMI--the fragility of fertility. Fertil Steril. 2004 Mar;81(3):727; author reply 727-8. PubMed PMID: 15037438.

57. Escudero E, Bosch E, Crespo J, Simón C, Remohí J, Pellicer A. Comparison of two different starting multiple dose gonadotropin-releasing hormone antagonist protocols in a selected group of in vitro fertilization-embryo transfer patients. Fertil Steril. 2004 Mar;81(3):562-6. PubMed PMID: 15037403.

58. Bosch E, Valencia I, Escudero E, Crespo J, Simón C, Remohí J, Pellicer A. Premature luteinization during gonadotropin-releasing hormone antagonist cycles and its relationship with in vitro fertilization outcome. Fertil Steril. 2003 Dec;80(6):1444-9. PubMed PMID: 14667881.

59. Bellver J, Muñoz EA, Ballesteros A, Soares SR, Bosch E, Simón C, Pellicer A,  Remohí J. Intravenous albumin does not prevent moderate-severe ovarian hyperstimulation syndrome in high-risk IVF patients: a randomized controlled study. Hum Reprod. 2003 Nov;18(11):2283-8. PubMed PMID: 14585874.

60. Bellver J, Rossal LP, Bosch E, Zúñiga A, Corona JT, Meléndez F, Gómez E, Simón C, Remohí J, Pellicer A. Obesity and the risk of spontaneous abortion after oocyte donation. Fertil Steril. 2003 May;79(5):1136-40. 

61. Troncoso C, Bosch E, Rubio C, Remohí J, Simón C, Pellicer A. The origin of biochemical pregnancies: lessons learned from preimplantation genetic diagnosis.   Fertil Steril. 2003 Feb;79(2):449-50..

62. Pellicer A, Navarro J, Bosch E, Garrido N, Garcia-Velasco JA, Remohí J, Simón C. Endometrial quality in infertile women with endometriosis. Ann N Y Acad Sci. 2001 Sep;943:122-30. Review. 

CLINICAL STUDIES IN RELEVANT AREA (including responsibilities): 

Endometrial development in oocyte donors treated with either high- or standard-dose GnRH antagonist compared to treatment with a GnRH agonist or in natural cycles (2005). Sub-investigator.

Serum luteinizing hormone in patients undergoing ovarian stimulation with gonadotropin-releasing hormone antagonists and recombinant follicle-stimulating hormone and its relationship with cycle outcome. (2005). Principal Investigator

Highly purified hMG versus recombinant FSH in ovarian hyperstimulation with GnRH antagonists. (2008). Principal Investigator.

GnRH agonist administration at the time of implantation in intrauterine insemination cycles (2009) Sub-Investigator

Impact of luteinizing hormone administration on gonadotropin-releasing hormone antagonist cycles (2010). Principal Investigator.

Embryoaneuploidy in natural ve stimulated cycles (2009-2011) (sub-investigator)

Endometrial receptivity in women with high circulating progesterone levels at the end of the follicular phase: a functional genomics analysis (2011). Sub-investigator

Human derived recombinant FSH, Phase II (Study-9 by Ferring- 2012): Principal Investigator

Barusiban to prevent uterine contractions in IVF patients (Basic study, by Ferring, 2012-13). Principal investigator and signing investigator.

Serum AMH and correlation with antral follicle count (by Roche diagnosis 2013). Principal investigator.

Recombinant LH in low responders (by MerckSerono, 2014). Principal investigator

Human derived recombinant FSH, phase III (by Ferring, 2014). Principal investigator.

Luteal phase support with duphaston (Study Lottus-1 by Abbott, 2014). Principal investigator.

Placebo controlled study of nolasiban to improve pregnancy rates in women undergoing IVF/ICSI (Implant-2)

Ongoing pregnancy rates in oocyte donation according to serum P levels de day of embryo transfer. Sub investigator (2017)

Follicular steroidgenesis in controlled ovarian stimulation. Principal Investigator (2018).

Comparison of hhCG with hCG+ß in the early prediction of ongoing pregnancy after in-vitro fertilization and embryo transfer. Principal investigator. (2018)

 

Serdar Bulun

Antonio Capalbo
Antonio Capalbo

Dr Capalbo has over 10 years’ experience in embryology and reproductive genetics.  He is currently Laboratory Director at Igenomix Italy and member of the Board of Research and Development Directors at Igenomix. He is also Senior Deputy for the SIG Reproductive Genetics of ESHRE.  His research has been focused on preimplantation genetic diagnosis and screening and on the development of novel molecular biology techniques reproductive genetics as well as in the basic study of mechanisms of aneuploidies in gametes and embryos. He received several grants for innovative studies on these subjects and published over 50 papers and book chapters in this field.  He also acts as editor for numerous international scientific journals.

Marcelle Cedars

Joseph Conaghan

Ángel Martín

Current Job

  • Research Embryologist at IVI RMA Valencia.

Education & Training

  • External University Lecturer. Universidad de Valencia, Spain.
  • PhD, Medicine. Universidad de Valencia, Spain.
  • MSc, Biotechnology of Assisted Human Reproduction. Universidad de Valencia, Spain.
  • Training at CARE Fertility Nottingham, United Kingdom.
  • BSc, Biotechnology. Universidad Pablo de Olavide, Spain.

Research Activity

  • Embryonic mosaicism
  • Early cell lineage specification

Selected publications

  • Zhu M, Shahbazi M*, Martin A*, Zhang C, Sozen B, Borsos M, Mandelbaum RS, Paulson RJ, Mole MA, Esbert M, Titus S, Scott RT, Campbell A, Fishel S, Gradinaru V, Zhao H, Wu K, Chen ZJ, Seli E, de Los Santos MJ, Zernicka Goetz M. Human embryo polarization requires PLC signaling to mediate trophectoderm specification. 2021 Sep 27;10:e65068. doi: 10.7554/eLife.65068. PMID: 34569938; PMCID: PMC8514238. *Equal contribution.
  • Martin A, Rodrigo L, Beltrán D, Meseguer M, Rubio C, Mercader A, de Los Santos MJ. The morphokinetic signature of mosaic embryos: evidence in support of their own genetic identity. Fertil Steril. 2021 Jul;116(1):165-173. doi: 10.1016/j.fertnstert.2020.12.031. Epub 2021 Mar 22. PMID: 33766460.
  • Kellam L, Pastorelli LM, Bastida AM, Senkbeil A, Montgomery S, Fishel S, Campbell A. Perivitelline threads in cleavage-stage human embryos: observations using time-lapse imaging. Reprod Biomed Online. 2017 Dec;35(6):646-656. doi: 10.1016/j.rbmo.2017.09.004. Epub 2017 Sep 28. PMID: 29074360.

Honors & Recognitions

  • Member of Spanish Association for the Study of Reproductive Biology (ASEBIR).
  • Member of European Society of Human Reproduction and Embryology (ESHRE) and American Society for Reproductive Medicine (ASRM).

Mauro Cozzolino

Michel De Vos
  • Current Job:  Michel De Vos, MD, PhD, is a senior medical director at Brussels IVF, the Centre for Reproductive Medicine at Universitair Ziekenhuis Brussel, Belgium and an associate professor in reproductive medicine at Vrije Universiteit Brussel.
  • Education & Training:   He studied medicine in Ghent, Belgium (MD 1997), has been a gynaecologist since 2006 and holds a PhD in medicine from the University of Leeds, United Kingdom (2007). In 2011, he was recognised as a subspecialist in reproductive medicine and surgery by ESHRE and the European Board and College of Obstetrics and Gynaecology (EBCOG).
  • Research Activity: His main research focus is on fertility treatment in women with polycystic ovary syndrome and on fertility preservation.
  • Honors & Recognitions: He is the current Chair of the In Vitro Maturation Special Interest Group of the ASRM. He is a member of the Female Oncofertility Scientific Committee of The Oncofertility Consortium of Michigan State University.

María José De Los Santos

Patricia Díaz-Gimeno

Francisco Domínguez

Mike Eisenberg

Marga Esbert

Caterina Exacoustos

Marcos Ferrando

Marcos Ferrando Serrano

Current Job

  • Medical Director IVI Bilbao (2009- ongoing)

Education & Training

  • Master’s degree in Medical Direction and Clinical Managemet, Instituto de Salud Carlos III.Ministerio de Sanidad. UNED. 2013
  • Master’s degree in Endoscopic gynecologycal surgery, Hospital La Fe, Valencia, 2010
  • Specialist in obstetrics and gynecology, Hospital La Fe, Valencia, 2007  
  • Master’s degree in Human Reproduction. Universidad Complutense de Madrid. Sociedad Española de Fertilidad. 2006.
  • Doctoral Program in Obstetrics and Gynaecology. Pediatrics, Obstetrics and Gynaecology Department. University of Valencia 2005.
  • Medicine and Surgery, University of Valencia, 2002.

Research Activity

  • Participation in 33 Clinical Research Projects (national and international), 24 of them as Principal Investigator and 9 as Secondary Researcher. . Some of these projects are founded by Basque Government:
  • ETORGAI in 2010
  • GAITEK. SPRI  in 2013, 2014
  • HAZITEK. SPRI. 2015, 2016, 2018
  • Author or co-author in 29 publications on assisted reproductive medicine
  • Author or co-author in 100 book chapters related to assisted reproductive medicine
  • Co-author in one book in the field of reproductive medicine
  • 78 abstracts at national and international congresses on Human Reproductive Medicine

Honors & Recognitions

  • Member of Spanish Obstetrics and Gynaecology Society (SEGO)
  • Member of Spanish Fertility Society (SEF) and European Society of Human Reproduction and Embryology (ESHRE)
  • Member of International Fertility Preservation Society
  • Best medical resident doctor award. 2007. Hospital La Fe.
  • Higher diploma in Research Methodology. Instituto San Carlos III. Ministerio de Sanidad.
  • Coordinator in several courses related to reproductive medicine.
  • Speaker at several national and international meetings related to reproductive medicine.

Nicolás Garrido

Nicolás Garrido Puchalt, Ph.D., M.Sc., is the Director of IVI Foundation, and Director of Research Administration at IVI RMA Global. Dr. Garrido obtained his B.Sc. in Biology from the University of Valencia in 1997, followed by a Post-graduate Research Fellowship at the Department of Gynaecology, Heinrich-Heine University, in Düsseldorf, Germany.

He obtained his Doctorate Degree from the University of Valencia in 2001, receiving the Extraordinary Prize in 2002, and a Master’s Degree in Research Methodology: Design and Statistics in Health Sciences from the Universitat Autònoma de Barcelona (UAB) in 2009, in Science and Innovation Management in 2018 and in Project Management in 2020, both from Universidad Politécnica de Valencia. He served as the Director of the Andrology Laboratory and Sperm Bank at the IVI University Institute in Valencia from 2000 until 2016, and lead the IVI Teaching Program starting in 2004, and afterwards the IVI Learning Center until 2017.

He is an Adjunct Professor at the University of Valencia, heading numerous research projects funded by the local and federal governments. His research interests include male infertility, sperm physiology, sperm selection techniques, biomarkers of fertility, and statistical approaches to measure ART success.

He authored or co-authored over 350 abstracts, wrote more than 80 book chapters, and 160 original or review articles in scientific journals. He received the Spanish Fertility Society Award in 2002 and 2004, the Spanish Urology Association Award in 2004, the American Society of Andrology Award (2007, 2010, 2011), and the Salud 2000 Foundation Award in 2010, among others.

Dr. Garrido is currently Section Editor at RBM Online, served as Associate Editor for Fertility and Sterility, and is also Ad Hoc Reviewer for the Journal of Assisted Reproduction Genetics, Reproductive BioMedicine Online, Human Reproduction, and Reproductive Biology and Endocrinology, and Andrology,  in the field, among others and as the editor for a textbook on Male Fertility.

Currently he is also the Coordinator for ESHRE of the Special Interest Group for Andrology.

Daniella Gilboa

Nobert Gleicher

Anne Gompel

Jacob Hanna
Prof. Jacob (Yaqub) Hanna, MD PhD

Department of Molecular Genetics

Born in Rama, an Arab Palestinian village in the Galilee region of Israel, Prof. Jacob (Yaqub) Hanna earned his BSc in medical science (2001), PhD in immunology (2007), and MD in clinical medicine summa cum laude (2007) from the Hebrew University of Jerusalem. He conducted postdoctoral research at the Whitehead Institute for Biomedical Research at MIT. He joined the department of Molecular Genetics at the Weizmann Institute in 2011.

Prof. Hanna is pioneering techniques in induced naïve pluripotency from adult cell and synthetic whole embryo models made solely from stem cells ex utero. Induced pluripotent stem (iPS) cells have regenerative properties almost identical to those of embryonic stem cells, but can be created from adult cells without using an egg or fetal material. Prof. Hanna was the lead researcher in a study that showed how further-modified iPS cells could be used to treat sickle-cell anemia in mice, the first proof of concept of the therapeutic application of iPS cells. Prof. Hanna has uncovered novel pathways regulating the reprogramming process and was the first to derive pristine “naïve” human pluripotent cells equivalent to those derived from mice and (i) can generate “cross-species humanized chimeric” mouse models that have human derived tissues (ii) can give rise to human primordial germ cell (progenitors of egg or sperm) or (iii) to all extra-embryonic compartments (placenta and yolk-sac). He was the first to expand prolonged periods of advanced and normal mammalian embryo development from pre-gastrulation until late organogenesis in an “artificial uterus” environment outside the maternal womb.  The latter platform enabled him to demonstrate the ability to be the first to generate advanced stage whole synthetic embryos made entirely from naïve pluripotent stem cells in the petri dish, that can complete gastrulation and demonstrate organ formation within adequate extra-embryonic compartments. In addition to demonstrating the power of cell reprogramming and ex utero synthetic advanced embryogenesis, his work offers the promise of powerful new research models for degenerative diseases, infertility, and modelling human early development.

During his postdoctoral work, Prof. Hanna received a prestigious Novartis Fellowship from the Helen Hay Whitney Foundation. In 2010, he was awarded the Sir Charles Clore Prize for Outstanding Appointment in the Weizmann Institute. He received an EMBO young investigator award (2012), a Rappaport Prize in biomedical research (2013), a Krill Prize by the Wolf Foundation (2013), and the Helen and Martin Kimmel Award for Innovative Investigation (2014). In 2014, he was featured among “40 under 40” innovative scientists by the prestigious journal Cell and was elected as a member of EMBO in 2018. In 2021, he ranked at the top of the list of 50 leading world thinkers by Prospect magazine.

Sonia Herraiz

Sonia Herraiz, Ph.D.- Biosketch

Dr. Sonia Herraiz is a full-time scientist at IVI Foundation leading the Ovarian rejuvenation and Fertility Preservation research group, visiting scholar at Stanford University Medical School in the Department of OB/GYN, member of the Reproductive Medicine group at the Instituto Investigación Sanitaria La Fe, and part of the Fertility Preservation Unit at La Fe University Hospital in Valencia. 

She graduated in Biology at University of Valencia in 2003, and joined IVI Foundation in 2006 where she obtained her PhD degree by the University of Valencia in 2010. 

Her scientific career is focused in the achievement of ovarian rejuvenation by several approaches like the autologous stem cell transplantation or the ovarian fragmentation. She is also focused in the development of new alternatives for Fertility Preservation in cancer patients where the ovarian transplantation is contraindicated, the improvement of ovarian tissue cryopreservation and transplantation techniques as well as. She has participated in several projects funded by the Spanish Ministry of Economy and the Valencian Health Agency as well as from different private institutions. 

As a researcher, she completed a one-year postdoctoral stay at the University of Edinburgh (2012-2013) and a 1.5-year stay at Stanford University (2016-2018). 

She has authored over 20 peer-reviewed scientific papers and book chapters in international journals and presented over 30 communications in congresses. She has been prized by the Spanish Fertility Society in 2016. Furthermore, is ad-hoc reviewer for different journals classed within the top-ten of Ob/Gyn and has been prized as Star reviewer by Fertility and Sterility. 

Professor in the Master’s Degree in Biotechnology of Assisted Human Reproduction (University of Valencia, UV) since 2016. Is co-director of 6 Thesis projects in UV and 3 Degree Final Project in Biotechnology at Polytechnic University of Valencia (UPV).

She has participated as a lecture in several courses and workshops organized by the International Society of Fertility Preservation, Spanish Society for Fertility, Spanish Society of Medical Oncology and IVI.

Education and Training

BSc                            University of Valencia (2003), Spain

PhD (Biology)          University of Valencia (2010), Spain 

Fellowship                University of Edinburgh (2012)

Fellowship                Stanford University School of Medicine (2016) 


Memberships

  • Member of the Society of Reproductive Investigation

2017

  • Visiting Scholar at OB/GYN department in Stanford University School of Medicine.

2016

  • Member of the reproductive Medicine research group at Medical Research Institute Hospital La Fe

2011

  • Fertility Preservation Program at Hospital La Fe University

2010

Teaching experience in Workshops and courses

  • IVI-Foundation “Gonadotropin-independent activation of follicular growth for women with compromised ovarian reserve: an update"

2017

  • I Campus SEF “Preservación de la Fertilidad”

2017

  • III Curso Preservación de la Fertilidad para oncólogos y hematólogos. Soc. Española Oncología Medica

2014

  • Hands-on workshop: Ovarian tissue vitrification and Slow freezing organized by ISFP. 

2013

  • I Curso Preservación de la Fertilidad para oncólogos y hematólogos. Soc. Española Oncología Medica

2014


Honors and Recognition

  • Spanish Fertility Society Award

2016

  • Fertility and Sterility Star Reviewer Award – Dr. Jacques Donnez Associate Editor

2016

  • Fertility and Sterility Star Reviewer Award – Dr. Nicolás Garrido Associate Editor

2016

  • Top five abstract at International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) 

2009

Linkedin: https://www.linkedin.com/in/sonia-herraiz-raya-6ab91719/

 

Jim Hotaling

Curriculum Vitae

Last Updated: 10/30/2018

PERSONAL DATA

Name: James M. Hotaling

Citizenship: United States

EDUCATION

Years

Degree

Institution (Area of Study)

1998 - 2002 

B.A. 

Dartmouth College (Biophysical Chemistry & History. Magna Cum Laude) 
 Hanover, NH 

2002 - 2006 

M.D. 

Duke University School of Medicine (Medicine) 
 Durham, NC 

2006 - 2007 

Intern 

University of Washington School of Medicine (Surgery) 
 Seattle, Washington 

2008 - 2012 

Resident 

University of Washington School of Medicine (Urology) 
 Seattle, Washington 

2009 - 2010 

M.S. 

University of Washington School of Public Health (Epidemiology) 
 Seattle, WA 

2012 - 2013 

Fellow 

University of Illinois at Chicago School of Medicine, Department of Urology (Andrology) 
 Chicago, IL 

BOARD CERTIFICATIONS

02/28/2016 - Present 

American Board of Urology, Certified 

CURRENT LICENSES/CERTIFICATIONS

2011 - Present 

DEA Certificate 

2014 - Present 

European Committee of Sexual Medicine: Certification 
 Description: Certified Specialist 

ACADEMIC HISTORY

Obstetrics/Gynecology (General OB/GYN), 05/17/2016 - Present 

05/17/2016 

Hire, Adjunct Track, Adjunct Assistant Professor 

Surgery (Urology), 09/15/2013 - Present 

09/15/2013 

Hire, Tenure Track - Clinician Scholar, Assistant Professor 

PROFESSIONAL EXPERIENCE 

Full-Time Positions

2013 - Present 

Assistant Professor, University of Utah, Salt Lake City, UT 

Editorial Experience

2012 - Present 

Interactive Associate Editor for Fertility & Sterility, online forum 

2014 - Present 

Speciality Editor for International Journal of Impotence Research 

2014 - Present 

Section Editor, Ytube Videos for Urology Times 

2016 - Present 

Section Editor, Male Infertility, Urology Times 

2016 - Present 

Specialty Editor for Fertility & Sterility 

2017 - Present 

Section Editor, Tech Talk With Steve & Jim, Urology Times 

2017 - Present 

Associate editor for Journal of Assisted Reproduction and Genetics 

Reviewer Experience

Ad Hoc Reviewer for Andrology 

Ad Hoc Reviewer for Fertility & Sterility 

Ad Hoc Reviewer for International Journal of Impotence Research 

Ad Hoc Reviewer for Journal of Urology 

Ad Hoc Reviewer for PLOS One Medicine 

Ad Hoc Reviewer for Systems Biology in Reproductive Medicine 

SCHOLASTIC HONORS

1998 - 1999 

Citations in General Chemistry and Molecular Biology, obtained the highest grade in the class for a given course. 

2000 

Richter Research Grant of $2100 to pursue research in chemistry. Dartmouth College. 

2002 

Honors in Chemistry graduate at Dartmouth College. 

2002 

Presidential Scholar Research Assistant. Dartmouth College. 

2004 

Duke Department of Orthopedics and General Surgery $10,000 scholarship. Duke University School of Medicine. 

2004 

Received Gold Star for excellent patient care. Duke University School of Medicine. 

2008 

American Urologic Association Western Section Resident Scholarship. University of Washington Department of Urology. 

2009 

International Volunteers in Urology Scholarship: $2500: to support travel to Uganda to work with Dr. Stephen Watya.
 University of Washington Department of Urology. 

2009 

Hirschler Prize for Innovative Urologic Research: $2000 for: “Development of a prospective database to standardize and track trauma outcomes”. University of Washington Department of Urology. 

2010 

Hirschler Prize for Innovative Urologic Research: $4000 for: “Sperm Cryopreservation Oncological Databank”. University of Washington Department of Urology. 

2010 

Summer Institute in Statistical Genetics Training Scholarship: $2400. University of Washington Department of Urology. 

2010 

AUA Annual Meeting Abstract selected for Meet the Press: “Long-term use of supplemental vitamin C, vitamin D and vitamin E does not reduce the risk of urothelial cell carcinoma of the bladder in the VITamins and Lifestyle study.” University of Washington Department of Urology. 

2010 

AUA Poster Selected as Best Poster in Session: “Isolated Teratospermia does not appear to predict clinical pregnancy following in vitro fertilization or in vitro fertilization with intracytoplasmic sperm injection: A systematic review and meta-analysis”. University of Washington Department of Urology. 

2010 

Northwest Institute of Genetic Medicine (NWIGM) Resource Grant for: “A Study of the Genetic Predictors of Erectile Dysfunction”.
 University of Washington Department of Urology. 

2010 

Warren Chapman Resident Research Award. University of Washington Department of Urology. 

2011 

SMRU Travelling Scholar $1000. 

2011 

Hirschler Prize for Innovative Urologic Research: $4000 for: “UWPNS360”. 

2013 

AUA Poster selected as Best Poster In Session: "Validity and Reliability of a Smartphone Application of the Assessment of Penile Deformity in Peyronie's Disease." 

2013 

Award of $5,000 from University of Illinois Enterprise Works for Sperm Dx Inc. 

2013 

Fertility & Sterility Reviewer of the Year Award 

2014 

Fertility and Sterility Reviewer of the Year Award 

2014 

AUA Poster selected as Best Poster in Session: " The Male Orgasm" 

2015 

StreamDx awarded 2nd place 2015 Utah Life Sciences Company of the Year, Utah Innovation Awards, Salt Lake City, Utah 

2015 

Trainee Merit Award, American Association of Andrology, 40th Annual Meeting 

2015 

Fertility and Sterility Reviewer of the Year Award 

2015 

The Effect of Spermatotoxic Medication Use on Semen Parameters of Subfertile Men - Best Poster at Western Sections American Urological Association 

2016 

Prize Abstract: Childhood Cancer Risk in the Siblings and Cousins of Men with Poor Semen Quality, 64th Annual Meeting of the Society for Pediatric Urology. San Diego, CA, May 6-8. 

2017 

2nd Place Prize for Best Poster "Population based semen analysis results and fertility among men with inflammatory bowel disease: results from the "SHARE Study" at the American College of Surgeons, Utah Chapter Meeting, Salt Lake City, May 11. 

2017 

Subfertility Health Assisted Reproduction and Environment (SHARE): Trans-generational impacts of male infertility. Early Career Investigator Showcase Selected for Oral Presentation. American Urologic Association Annual Meeting, Boston, May 12-16. 

ADMINISTRATIVE EXPERIENCE 

Professional Organization & Scientific Activities

2013 

Committee Member, International Consultation on Urological Diseases, American Society for Men's Health, International Consultation on Men's Health and Infertility, Committee on Epidemiology and Aging 

2013 

Contributing Member, International Consultation on Urological Diseases, American Society for Men's Health, International Consultation of Men's Health and Infertility, Committee on Infertility Treatment 

2015 - 2021 

Member, American Society for Reproductive Medicine, Video Committee 

2015 - Present 

Committee Member, Societe Internationale d' Urologie, Content Development for SIU Academy - Infertility/Men's Health, sub-committee of Multimedia Learning Committee 

2015 

Roundtable Moderator, American Society for Reproductive Medicine, Male infertility and comorbidities: Improving male health through proper evaluation. Scientific Congress, Baltimore, MA, Oct 17-21 

2015 

Co-Moderator, American Society for Reproductive Medicine, Male reproduction and urology: Traveling Scholars, Scientific Congress, Baltimore, MA, Oct 17-21 

2016 - 2019 

Member, American Society for Reproductive Medicine, Research Committee 

2016 

Task Force Member, American Society for Reproductive Medicine, SMRU Task Force on the role of sexual dysfunction in the male during infertility treatment. 

2016 

Abstract Reviewer, American Society for Reproductive Medicine, 72nd American Society for Reproductive Medicine 2016 Scientific Congress & Expo, Oct. 15-19, Salt Lake City, UT. 

2016 

Roundtable Moderator, American Society for Reproductive Medicine, Sexual Dysfunction and Male Infertility. 72nd American Society for Reproductive Medicine Scientific Congress & Expo, Oct 15-19, Salt Lake City, UT 

2016 

Co-Moderator, American Society for Reproductive Medicine, Oral Abstracts, Male Reproduction and Urology: Clinical 2, at the 72nd American Society for Reproductive Medicine Scientific Congress & Expo, Oct 15-19, Salt Lake City, UT 

2016 

Co-Moderator, American Society for Reproductive Medicine, Video Session 2, 72nd American Society for Reproductive Medicine Scientific Congress & Expo, October 17, Salt Lake City, UT. 

2016 

Invited Moderator, American Urological Association - Western Section, Sexual Medicine, 92nd Annual Meeting, Kauai, HI, Oct. 23-28. 

2017 - 2019 

Officer at Large, Society for the Study of Male Reproduction, (SSMR) American Urological Association 2017-2019 

2017 - Present 

Panel Member, American Urological Association, National Urology Research Agenda 2017 for male infertility, member of agenda panel for American Urological Association 

2017 

Abstract Reviewer, American Society for Reproductive Medicine, Scientific Congress, San Antonio, TX, Oct 28-Nov 1. 

2017 

Roundtable Moderator, American Society for Reproductive Medicine, Update on culturing human spermatogonial stem cells for oncofertility. Scientific Congress, San Antonio, TX, Oct 28-Nov 1. 

2018 - 2021 

Executive Board Member, American Society of Andrology, 2018-2021 

2018 - 2021 

Program Chair, American Urological Association - Western Section, Program Chair for Sexual Medicine/Andrology Content 

2018 

Session Co-Moderator, American Society for Reproductive Medicine, Video Session 2, 74th ASRM Scientific Congress & Expo, Denver, CO, Oct 6-10 

2018 

Conference Abstract Reviewer, American Society for Reproductive Medicine, 74th ASRM Scientific Congress & Expo, Denver, CO Oct. 6-10.
 
 

Grant Review Committee/Study Section

2016 

Pregnancy Risk Assessment Monitoring ad hoc study section member, Center for Disease Control 

2016 - 2018 

ASRM Research Grant Reviewer 

PROFESSIONAL COMMUNITY ACTIVITIES

2013 

Interviewee, Clear Channel Radio, on hypogonadism 

2014 

Interviewee, KTVX TV, Good Things Utah appearance on Men's Health 

2014 

Interviewee, KUED, Male Infertility 

2015 

Interviewee, KUTV TV, Men's Health 

2016 

Interviewee, KUTV TV, Vas Madness 

2017 

Interviewee, Brides.com, Male Factor Infertility: What You Need to Know 

2018 

Interviewee, Furthermore from Equinox, Shortsleeve,C, Furthermore.equinox.com; Don’t Overdo Ibuprofen New research shows the anti-inflammatory might negatively affect male fertility. 

UNIVERSITY COMMUNITY ACTIVITIES 

University Level

2013 

Presenter, Utah Center for Reproductive Medicine, Testicular Sperm Extraction 

2014 - Present 

Member, Entrepreneurial Faculty Scholars 

2014 - Present 

Presenter & Member, Utah Center for Reproductive Medicine, Pathways to Pregnancy 

2014 

Presenter, Utah Center for Reproductive Medicine, Fresh Vs. Frozen Sperm for IVF, Nov. 21 

Health Sciences Level

2014 - 2016 

Co-Founder, Health Sciences Center, Men's Health Center 

2014 - Present 

Co-Medical Director, Fertility Integrated Practice Unit 

2016 - Present 

Member, Health Sciences Center, Men's Health Shared Governance Board 

University Hospitals & Clinics

2015 - 2016 

Member, University of Utah Hospitals and Clinics, EPIC Urology Division update for SmartForms 

Department Level

2017 - Present 

Co-Director/Director, Surgery, Population Data Research Core 

Programs, Centers & Institutes

2015 - Present 

Member, Huntsman Cancer Institute, Genitourinary Disease Orientation Team 

CURRENT MEMBERSHIPS IN PROFESSIONAL SOCIETIES

American Diabetes Association 

American Society for Reproductive Medicine 

American Society of Andrology 

American Urological Association 

European Association for the Study of Diabetes 

European Society for Sexual Medicine 

Northwest Urological Society 

Society for Male Reproduction and Urology 

Society for the Study of Male Reproduction 

World Professional Association for Transgender Health 

FUNDING 

Active Grants

09/10/14 - 05/30/19 

Genomics of spermatogenic impairment. (1R01HD78641) 
 Principal Investigator: Kenneth I. Aston 
 Direct Costs: $2,354,426    Total Costs: $3,508,095 
 National Institute of Child Health and Human Development 
Role: Co-Investigator 

02/24/15 - 01/31/18 

Transgenerational effects of smoking-induced changes to Sperm DNA. (1R01HD082062) 
 Direct Costs: $415,000    Total Costs: $618,350 
 National Institute of Child Health and Human Development 
Role: Co-Investigator 

07/01/15 - 06/30/18 

Impact of diet, exercise and lifestyle on fertility: The IDEAL fertility study. (N275201500001C) 
 Direct Costs: $2,039,544    Total Costs: $3,038,921 
 National Institute of Child Health and Human Development 
Role: Co-Investigator 

07/01/16 - 06/30/19 

Susceptibility Genes for Erectile Dysfunction ED eMERGE (1R01DK104764) 
 Principal Investigator: James M. Hotaling 
 Direct Costs: $450,000    Total Costs: $670,500 
 National Institute of Diabetes and Digestive and Kidney Diseases 
Role: Co-Principal Investigator 

04/03/17 - 03/31/19 

Stream Dx: accurate and efficient, point-of-care uroflometry for improved diagnosis, monitoring, and post-treatment evaluation of LUTS 
 Principal Investigator: James M. Hotaling 
 Direct Costs: $1,111,171    Total Costs: $1,493,493 
 SBIR NIKKDK 
Role: Principal Investigator 

12/01/17 - 11/30/19 

Sperm Epigenetic Profiling & Embryonic Competence 
 Direct Costs: $450,000    Total Costs: $450,000 
 Foundation for Embryonic Competence 
Role: Principal- Investigator 

04/20/18 - 04/20/20 

Sperm sample preparation for point of care applications 
 Direct Costs: $1,225,000    Total Costs: $1,225,000 
 National Institute of Child Health and Human Development 
Role: co-Investigator 

Pending Grants

04/01/18 - 03/31/19 

MiOXSYS 
 Principal Investigator: James M. Hotaling 
 AYTU BioScience, Inc. 
Role: Principal Investigator 

02/01/19 - 07/31/21 

Sbir Nanonc Sept2018 
 Principal Investigator: James M. Hotaling 
 Nanonc Inc 
Role: Principal Investigator 

Past Grants

01/01/09 - 12/31/09 

NIH T-32 Training Grant, University of Washington 
 Direct Costs: $55,000    Total Costs: $55,000 
 National Institutes of Health 
Role: Recipient 

07/01/09 - 07/01/10 

Genome wide association search identifies potential loci for risk of erectile dysfunction in type 1 Diabetes using the epidemiology of Diabetes interventions and complications study cohort. 
 National Institute of Diabetes and Digestive and Kidney Diseases 
Role: Investigator 

01/01/10 - 12/31/10 

Institute for Translational Health Research (ITHS) Grant: “Development and Validation of a Rapid, Sutureless Circumcision Device to facilitate Dissemination of Safe Adult Male Circumcision to reduce HIV Infection Rates in Africa.” 
 Principal Investigator: James M. Hotaling 
 Direct Costs: $10,000    Total Costs: $10,000 
 University of Washington 
Role: Co-Principal Investigator 

10/01/10 - 10/01/11 

Novel single nucleotide polymorphisms may predict ED: Data from the Group Health Adult Changes in Thought Study 
 Northwest Institute of Genetic Medicine 
Role: Co Principal Investigator 

04/01/11 - 04/01/12 

Development and validation of a rapid, sutureless circumcision device to facilitate dissemination of safe adult male circumcision to reduce HIV infection rates in Africa 
 University of Washington Institute of Translational Health Sciences 
Role: Co Principal Investigator 

08/01/13 - 07/31/15 

URO-EDICII: Risk and Progression of Urologic Complications in Type 1 -Diabetes 
 Principal Investigator(s): Aruua Sarma; Hunter Wessells 
 Direct Costs: $37,813    Total Costs: $56,340 
 University of Washington 
Role: Consultant 

09/01/14 - 01/01/15 

StreamDX 
 Principal Investigator: James M. Hotaling 
 Direct Costs: $10,000    Total Costs: $10,000 
 University of Utah Engine Funding Program 
Role: Principal Investigator 

12/01/14 - 12/01/15 

StreamDX 
 Principal Investigator: James M. Hotaling 
 Direct Costs: $50,000    Total Costs: $50,000 
 University of Utah Technology Commercialization Office 
Role: Principal Investigator 

01/01/15 - 12/31/15 

Development of a novel microfluidics device to optimize sperm retrieval and storage from micro dissection testicular sperm extraction mTESE 
 Principal Investigator: James M. Hotaling 
 Direct Costs: $35,000    Total Costs: $35,000 
 University of Utah Research Foundation Seed Grant 
Role: Principal Investigator 

01/01/15 - 12/31/15 

Testosterone Concentrations and Cardiovascular Disease in Men with Type 1 Diabetes. DiaComp Pilot &Feasibility Project 
 Principal Investigator: Aruna Sarma 
 Georgia Regents University DiaComp Coordinating and Bioinformatics Unit 
Role: Consultant 

04/30/15 - 04/30/16 

StreamDx 
 Principal Investigator: James M. Hotaling 
 Direct Costs: $6,500    Total Costs: $6,500 
 University of Utah Entrepreneurship Club 
Role: Principal Investigator 

05/12/15 - 12/31/15 

Raman Spectrometer for Novel Microfluidics Applications 
 Principal Investigator: James M. Hotaling 
 Direct Costs: $35,000    Total Costs: $35,000 
 University of Utah Research Instrumentation Fund 
Role: Principal Investigator 

07/01/16 - 06/30/17 

Development of a Novel Microfluidics Device to Optimize Sperm
 Retrieval and Storage from Microsurgical Testicular Sperm Extraction. NANONC Inc. STTR Phase I (NSF 1549659) 
 Principal Investigator: James M. Hotaling 
 Direct Costs: $225,000    Total Costs: $225,000 
 National Science Foundation 
Role: Principal Investigator 

TEACHING RESPONSIBILITIES/ASSIGNMENTS 

Course Lectures

2014 

Instructor, MS2: Lecture "Men's Health 101", University of Utah 

2014 

Instructor, MS2: Lecture "The GU History and Physical", University of Utah 

2015 

Instructor, MS2: Lecture "Men's Health 101", University of Utah 

2015 

Instructor, MS2: Lecture "The GU History and Physical", University of Utah 

Clinical Teaching

2015 - Present 

Developed Male Infertility Clinical Program for Reproductive Endocrinology Fellows 

2015 - Present 

Co-director of Reconstructive Urology Fellowship 

Small Group Teaching

2014 - 2016 

Microsurgical Course, Urology, University of Utah School of Medicine, Residents 

Trainee Supervision

Fellow 

2013 - 2014 

Supervisor, Kristin Murphy, University of Utah. Male infertility/genetics 

2013 - 2015 

Supervisor, Monis Bilal Shamsi, University of Utah. Male infertility/genetics 

2013 - 2014 

Supervisor, Jeff Redshaw, University of Utah. Urology Research Fellow 

2014 - Present 

Supervisor, Raheel Samuel, University of Utah 

2014 - 2015 

Supervisor, Darshan Patel, University of Utah 

2015 - 2016 

Supervisor, Jason Chandrapal, University of Utah 

2016 - 2017 

Supervisor, James Craig, University of Utah 

2016 - Present 

Supervisor, Soren Keiheui, University of Utah 

PhD/Doctorate 

2014 - 2017 

Supervisor, Jiyoung Son, University of Utah. Mechanical Engineering 

2014 - Present 

Supervisor, Jingtao Guo, University of Utah 

MD, PhD 

2013 - 2014 

Supervisor, John Gannon, University of Utah. Urology Resident 

2014 - Present 

Supervisor, Jeff Redshaw, University of Utah 

2015 - Present 

Supervisor, Darshan Patel, University of Utah 

2015 - Present 

Supervisor, Ross Anderson, University of Utah 

2015 - 2017 

Supervisor, Vera Trofemenko, University of Utah 

Educational Lectures 

Didactic Lectures

2013 

Pathways to Pregnancy with Dr. Ahmad Hammoud 

2014 

Microscopy skills with Urology Residents 

2014 

Pathways to Pregnancy with Dr. Andrew Moore 

2014 

Chemotherapy and Spermatogenesis, presented to HCI Oncologists 

2014 

Erectile dysfunction and male infertility, 2nd year med students, University of Utah 

2015 

Erectile dysfunction and male infertility, 2nd year med students, University of Utah 

Continuing Education 

CE Courses Developed

2013 - Present 

Surgical Management for Male Infertility. American Urological Association Core Curriculum. 

2016 

Trofimenko V, Jenkins TG, Carrell DT, Hotaling JM. Genetics in Urology: A Urologists Guide. American Urological Association Update Series, Vol 35. 

2017 

Developing A Men's Health Center Post Graduate Course, American Urological Association, May 12, Boston. 

CE Courses Taught

2016 

Value-based Care of the Infertile Male, 49th Annual Pre-Congress Program, 72nd American Society for Reproductive Medicine Scientific Congress & Expo, October 15-19, Salt Lake City, UT 

2017 

Developing A Men's Health Center Post Graduate Course, AUA May 12, 2017 Boston. 

PEER-REVIEWED JOURNAL ARTICLES

1.

Hotaling J, Mulhall JP (1999). Chronology of venous leak development following radical prostatectomy. J Urol, 16(4), 1055A.

2.

Mulhall JP, Slovick R, Hotaling J, Aviv N, Valenzuela R, Waters WB, Flanigan RC (2002). Erectile dysfunction after radical prostatectomy: hemodynamic profiles and their correlation with the recovery of erectile function. J Urol, 167(3), 1371-5.

3.

Moul JW, Sun L, Hotaling JM, Fitzsimons NJ, Polascik TJ, Robertson CN, Dahm P, Anscher MS, Mouraviev V, Pappas PA, Albala DM (2007). Age adjusted prostate specific antigen and prostate specific antigen velocity cut points in prostate cancer screening. J Urol, 177(2), 499-503; discussion 503-4.

4.

Sun L, Moul JW, Hotaling JM, Rampersaud E, Dahm P, Robertson C, Fitzsimons N, Albala D, Polascik TJ (2007). Prostate-specific antigen (PSA) and PSA velocity for prostate cancer detection in men aged <50 years. BJU Int, 99(4), 753-7.

5.

Freedland SJ, Hotaling JM, Fitzsimons NJ, Presti JC Jr, Kane CJ, Terris MK, Aronson WJ, Amling CL (2008). PSA in the new millennium: a powerful predictor of prostate cancer prognosis and radical prostatectomy outcomes--results from the SEARCH database. Eur Urol, 53(4), 758-64; discussion 765-6.

6.

Wright JL, Hotaling J, Porter MP (2009). Predictors of Upper Tract Urothelial Cell Carcinoma after Primary Bladder Cancer: A Population Based Analysis. J Urol, 181(3), 1035-1039.

7.

Hotaling JM, Shear S, Lendvay TS (2009). 14-gauge angiocatheter: the assist port. J Laparoendosc Adv Surg Tech A, 19(5), 699-701.

8.

Wright JL, Risk MC, Hotaling J, Lin DW (2009). Effect of collecting duct histology on renal cell cancer outcome. J Urol, 182(6), 2595-9.

9.

Hotaling JM, Sorensen MD, Smith TG 3rd, Rivara FP, Wessells H, Voelzke BB (2011). Analysis of diagnostic angiography and angioembolization in the acute management of renal trauma using a national data set. J Urol, 185(4), 1316-20.

10.

Hotaling JM, Wright JL, Pocobelli G, Bhatti P, Porter MP, White E (2011). Long-term use of supplemental vitamins and minerals does not reduce the risk of urothelial cell carcinoma of the bladder in the VITamins And Lifestyle study. J Urol, 185(4), 1210-5.

11.

Hotaling JM, Davenport MT, Eisenberg ML, VanDenEeden SK, Walsh TJ (2012). Men who seek infertility care may not represent the general U.S. population: data from the National Survey of Family Growth. Urology, 79(1), 123-7.

12.

Vanni AJ, Hotaling J, Hamlat C, Jurkovich GJ, Voelzke BB (2012). Do inclusive trauma systems improve outcomes after renal trauma? J Trauma Acute Care Surg, 72(2), 385-9.

13.

Hotaling JM, Wang J, Sorensen MD, Rivara FP, Gore JL, Jurkovich J, McClung CD, Wessells H, Voelzke BB (2012). A national study of trauma level designation and renal trauma outcomes. J Urol, 187(2), 536-41.

14.

Anawalt BD, Hotaling JM, Walsh TJ, Matsumoto AM (2012). Performance of total testosterone measurement to predict free testosterone for the biochemical evaluation of male hypogonadism. J Urol, 187(4), 1369-73.

15.

Jacobs MA, Hotaling JM, Mueller BA, Koyle M, Rivara F, Voelzke BB (2012). Conservative management vs early surgery for high grade pediatric renal trauma--do nephrectomy rates differ? J Urol, 187(5), 1817-22.

16.

Hotaling JM, Walsh TJ, Macleod LC, Heckbert S, Pocobelli G, Wessells H, White E (2012). Erectile dysfunction is not independently associated with cardiovascular death: data from the vitamins and lifestyle (VITAL) study. J Sex Med, 9(8), 2104-2110.

17.

Hotaling JM, Walsh TJ, Macleod LC, Heckbert S, Pocobelli G, Wessells H, White E (2012). Erectile dysfunction is not independently associated with cardiovascular death: data from the vitamins and lifestyle (VITAL) study. J Sex Med, 9(8), 2104-10.

18.

Hotaling JM, Waggott DR, Goldberg J, Jarvik G, Paterson AD, Cleary PA, Lachin J, Sarma A, Wessells H (2012). Pilot genome-wide association search identifies potential loci for risk of erectile dysfunction in type 1 diabetes using the DCCT/EDIC study cohort. J Urol, 188(2), 514-20.

19.

Hotaling JM, Lopushnyan NA, Davenport M, Christensen H, Pagel ER, Muller CH, Walsh TJ (2013). Raw and test-thaw semen parameters after cryopreservation among men with newly diagnosed cancer. Fertil Steril, 99(2), 464-9.

20.

Macleod L, Hotaling J, Wright JL, Gore JL, Harper J, White E (2013). Risk factors for renal cell carcinoma in the VITAL study. Urol Oncol, 190(5), 1657-1661.

21.

Walsh TJ, Hotaling JM, Lue TF, Smith JF (2013). How curved is too curved? The severity of penile deformity may predict sexual disability among men with Peyronie's disease. Int J Impot Res, 25(3), 109-12.

22.

Hsi RS, Hotaling JM, Moore TN, Joyner BD (2013). Publication misrepresentation among urology residency applicants. World J Urol, 31(3), 697-702.

23.

Hsi RS, Hotaling JM, Hartzler AL, Holt SK, Walsh TJ (2013). Validity and reliability of a smartphone application for the assessment of penile deformity in Peyronie's disease. J Sex Med, 10(7), 1867-1873.

24.

McClung C, Hotaling J, Wang J, Wessells H, Voelzke B (2013). Contemporary trends in the immediate surgical management of renal trauma using a national database. J Trauma Acute Care Surg, 75(4), 602-606.

25.

Shih C, Hotaling JM, Wright JL, White E (2013). Long-term NSAID use and incident urothelial cell carcinoma in the VITamins and Lifestyle (VITAL) study. Urol Oncol, 31(8), 1689-95.

26.

Holt S, Lopushnyan N, Hotaling J, Sarma A, Wessells H (2014). Prevalence of Androgen Deficiency and Predisposing Risk Factors in Men with Type I Diabetes Mellitus: Findings from the DCCT/EDIC. J Clin Endocrinol Metab.

27.

Welty CJ, Wright JL, Hotaling JM, Bhatti P, Porter MP, White E (2014). Persistence of urothelial carcinoma of the bladder risk among former smokers: results from a contemporary, prospective cohort study. Urol Oncol, 32(1), 25.e21-5.

28.

Walsh TJ, Hotaling JM, Smith A, Saigal C, Wessells H (2014). Men with diabetes may require more aggressive treatment for erectile dysfunction. Int J Impot Res, May-Jun;26(3), 112-115.

29.

Kosova G, Hotaling JM, Ohlander S, Niederberger C, Prins GS, Ober C (2014). Variants in DPF3 and DSCAML1 are associated with sperm morphology. J Assist Reprod Genet, 31(2), 131-7.

30.

Ohlander S, Hotaling J, Kirshenbaum E, Niederberger C, Eisenberg ML (2014). Impact of fresh versus cryopreserved testicular sperm upon intracytoplasmic sperm injection pregnancy outcomes in men with azoospermia due to spermatogenic dysfunction: a meta-analysis. Fertil Steril, 101(2), 344-9.

31.

Hotaling J, Carrell DT (2014). Clinical genetic testing for male factor infertility: current applications and future directions. Andrology, 2(3), 339-50.

32.

Hotaling JM, Leddy LS, Haider MA, Mossanen M, Bailey MR, MacConaghy B, Olson F, Krieger JN (2014). Simple circumcision device: proof of concept for a single-visit, adjustable device to facilitate safe adult male circumcision. Fertil Steril, 101(5), 1266-70.

33.

Simon L, Liu L, Murphy K, Ge S, Hotaling J, Aston KI, Emery B, Carrell DT (2014). Comparative analysis of three sperm DNA damage assays and sperm nuclear protein content in couples undergoing assisted reproduction treatment. Hum Reprod, 29(5), 904-17.

34.

Kadlec AO, Ohlander S, Hotaling J, Hannick J, Niederberger C, Turk TM (2014). Nonlinear logistic regression model for outcomes after endourologic procedures: a novel predictor. Urolithiasis, 42(4), 323-7.

35.

Holt SK, Lopushnyan N, Hotaling J, Sarma AV, Dunn RL, Cleary PA, Braffett BH, Gatcomb P, Martin C, Herman WH, Wessells H (2014). Prevalence of low testosterone and predisposing risk factors in men with type 1 diabetes mellitus: findings from the DCCT/EDIC. J Clin Endocrinol Metab, 99(9), E1655-60.

36.

Myers JB, Hotaling JM, Brant WO (2014). Editorial comment. Urology, 84(4), 933.

37.

Grimsby GM, Voelzke B, Hotaling J, Sorensen MD, Koyle M, Jacobs MA (2014). Demographics of pediatric renal trauma. J Urol, 192(5), 1498-502.

38.

Simon L, Murphy K, Shamsi MB, Liu L, Emery B, Aston KI, Hotaling J, Carrell DT (2014). Paternal influence of sperm DNA integrity on early embryonic development. Hum Reprod, 29(11), 2402-12.

39.

Hotaling JM, Cohen AL, Shiffrin RM, Busemeyer JR (2015). The Dilution Effect and Information Integration in Perceptual Decision Making. PLoS One, 10(9), e0138481.

40.

Parthiban S, Hotaling JM, Kathrins M, Baftiri AP, Freels S, Niederberger CS (2015). A novel method to determine perineal artery occlusion among male bicyclists. PeerJ, 3, e1477.

41.

Simon L, Murphy K, Aston KI, Emery BR, Hotaling JM, Carrell DT (2015). Micro-electrophoresis: a noninvasive method of sperm selection based on membrane charge. Fertil Steril, 103(2), 361-6.e3.

42.

Schliep KC, Mumford SL, Ahrens KA, Hotaling JM, Carrell DT, Link M, Hinkle SN, Kissell K, Porucznik CA, Hammoud AO (2015). Effect of male and female body mass index on pregnancy and live birth success after in vitro fertilization. Fertil Steril, 103(2), 388-95.

43.

Sarma AV, Hotaling J, Dunn RL, Cleary PA, Braffett BH, Kim C, Martin C, Herman W, Gatcomb P, Jacobson AM, Holt SK, Wessells H (2015). Poor glycemic control is associated with reduced prostate specific antigen concentrations in men with type 1 diabetes. J Urol, 193(3), 786-93.

44.

Myers JB, Hotaling JM, Brant WO, Enniss TM (2015). Management of a Case of Severe Pelvic Fracture Related Bladder Trauma. Urol Case Rep, 3(2), 32-4.

45.

Jenkins TG, Aston KI, Trost C, Farley J, Hotaling JM, Carrell DT (2015). Intra-sample heterogeneity of sperm DNA methylation. Mol Hum Reprod, 21(4), 313-9.

46.

Patel DP, Brant WO, Myers JB, Zhang C, Presson AP, Johnstone EB, Dorais JA, Aston KI, Carrell DT, Hotaling JM (2015). Sperm concentration is poorly associated with hypoandrogenism in infertile men. Urology, 85(5), 1062-1067.

47.

Pop-Busui R, Hotaling J, Braffett BH, Cleary PA, Dunn RL, Martin CL, Jacobson AM, Wessells H, Sarma AV (2015). Cardiovascular autonomic neuropathy, erectile dysfunction and lower urinary tract symptoms in men with type 1 diabetes: findings from the DCCT/EDIC. J Urol, 193(6), 2045-51.

48.

Patel DP, Redshaw JD, Breyer BN, Smith TG, Erickson BA, Majercik SD, Gaither TW, Craig JR, Gardner S, Presson AP, Zhang C, Hotaling JM, Brant WO, Myers JB (2015). High-grade renal injuries are often isolated in sports-related trauma. Injury, 46(7), 1245-9.

49.

Hotaling JM, Patel DP, Brant WO, Myers JB, Cullen MR, Eisenberg ML (2015). Demographic and socio-economic differences between men seeking infertility evaluation and those seeking surgical sterilization: from the National Survey of Family Growth. BJU Int, 116(2), 288-92.

50.

Son J, Murphy K, Samuel R, Gale BK, Carrell DT, Hotaling JM (2015). Non-motile sperm cell separation using a spiral channel. Anal Methods, 7, 8041-8047.

51.

Patel DP, Brant WO, Myers JB, Presson AP, Johnstone EB, Dorais JA, Aston KI, Carrell DT, Hotaling JM (2015). The safety and efficacy of clomiphene citrate in hypoandrogenic and subfertile men. Int J Impot Res, 27(6), 221-4.

52.

Parthiban S, Hotaling JM, Kathrins M, Baftiri AP, Freels S, Niederberger CS (2015). A Novel Method to Determine Perineal Artery Occlusion among Male Bicyclists. PeerJ.

53.

Patel DP, Elliott SP, Stoffel JT, Brant WO, Hotaling JM, Myers JB (2016). Patient reported outcomes measures in neurogenic bladder and bowel: A systematic review of the current literature. Neurourol Urodyn, 35(1), 8-14.

54.

Jenkins TG, Aston KI, Meyer TD, Hotaling JM, Shamsi MB, Johnstone EB, Cox KJ, Stanford JB, Porucznik CA, Carrell DT (2016). Decreased fecundity and sperm DNA methylation patterns. Fertil Steril, 105(1), 51-7.e1-3.

55.

Hanson HA, Anderson RE, Aston KI, Carrell DT, Smith KR, Hotaling JM (2016). Subfertility increases risk of testicular cancer: evidence from population-based semen samples. Fertil Steril, 105(2), 322-8.e1.

56.

Patel DP, Schenk JM, Darke A, Myers JB, Brant WO, Hotaling JM (2016). Non-steroidal anti-inflammatory drug (NSAID) use is not associated with erectile dysfunction risk: results from the Prostate Cancer Prevention Trial. BJU Int, 117(3), 500-6.

57.

Orchard J, Tward JD, Lenherr S, Hotaling JM, Brant WO, Myers JB (2016). Surgical Management of Ureteral Strictures Arising From Radiotherapy for Prostate Cancer. Urol Case Rep, 6, 47-9.

58.

Samuel R, Badamjav O, Murphy KE, Patel DP, Son J, Gale BK, Carrell DT, Hotaling JM (2016). Microfluidics: The future of microdissection TESE? Syst Biol Reprod Med, 62(3), 161-70.

59.

Simon L, Murphy K, Aston KI, Emery BR, Hotaling JM, Carrell DT (2016). Optimization of microelectrophoresis to select highly negatively charged sperm. J Assist Reprod Genet, 33(6), 679-88.

60.

Anderson RE, Hanson HA, Patel DP, Johnstone E, Aston KI, Carrell DT, Lowrance WT, Smith KR, Hotaling JM (2016). Cancer risk in first- and second-degree relatives of men with poor semen quality. Fertil Steril, 106(3), 731-8.

61.

Hotaling JM, Sarma AV, Patel DP, Braffett BH, Cleary PA, Feldman E, Herman WH, Martin CL, Jacobson AM, Wessells H, Pop-Busui R (2016). Cardiovascular Autonomic Neuropathy, Sexual Dysfunction, and Urinary Incontinence in Women With Type 1 Diabetes. Diabetes Care, 39(9), 1587-93.

62.

Jenkins TG, Aston KI, Hotaling JM, Shamsi MB, Simon L, Carrell DT (2016). Teratozoospermia and asthenozoospermia are associated with specific epigenetic signatures. Andrology, 4(5), 843-9.

63.

Craig JR, Hotaling J, Brant WO (2016). Editorial Comment. J Urol, 196(4), 1089.

64.

Lenherr SM, Clemens JQ, Braffett BH, Cleary PA, Dunn RL, Hotaling JM, Jacobson AM, Kim C, Herman W, Brown JS, Wessells H, Sarma AV, DCCT/EDIC Research Group (2016). Glycemic control and urinary tract infections in women with Type-1 Diabetes: Results from the DCCT/EDIC. J Urol, 196(4), 1129-1135.

65.

Lenherr SM, Clemens JQ, Braffett BH, Dunn RL, Cleary PA, Kim C, Herman WH, Hotaling JM, Jacobson AM, Brown JS, Wessells H, Sarma AV (2016). Glycaemic control and risk of incident urinary incontinence in women with Type 1 diabetes: results from the Diabetes Control and Complications Trial and Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) study. Diabet Med, 33(11), 1528-1535.

66.

Chandrapal JC, Nielson S, Patel DP, Zhang C, Presson AP, Brant WO, Myers JB, Hotaling JM (2016). Characterizing the safety of clomiphene citrate in male patients through prostate-specific antigen, hematocrit, and testosterone levels. Br J Urol, 118(6), 272.

67.

Hanson HA, Mayer EN, Anderson RE, Aston KI, Carrell DT, Berger J, Lowrance WT, Smith KR, Hotaling JM (2017). Risk of childhood mortality in family members of men with poor semen quality. Hum Reprod, 32(1), 239-247.

68.

Anderson RE, Hanson HA, Lowrance WT, Redshaw J, Oottamasathien S, Schaeffer A, Johnstone E, Aston KI, Carrell DT, Cartwright P, Smith KR, Hotaling JM (2017). Childhood Cancer Risk in the Siblings and Cousins of Men with Poor Semen Quality. J Urol, 197(3 Pt 2), 898-905.

69.

Simon L, Aston KI, Emery BR, Hotaling J, Carrell DT (2017). Sperm DNA damage output parameters measured by the alkaline Comet assay and their importance.LID - 10.1111/and.12608 [doi]. Andrologia, 49(2).

70.

Rao PK, Boulet SL, Mehta A, Hotaling J, Eisenberg ML, Honig SC, Warner L, Kissin DM, Nangia AK, Ross LS (2017). Trends in Testosterone Replacement Therapy Use from 2003 to 2013 among Reproductive-Age Men in the United States. J Urol, 197(4), 1121-1126.

71.

Mayer EN, Tward JD, Bassett M, Lenherr SM, Hotaling JM, Brant WO, Lowrance WT, Myers JB (2017). Management of Radiation Therapy Oncology Group grade 4 urinary adverse events after radiotherapy for prostate cancer. BJU Int, 119(5), 700-708.

72.

Son J, Samuel R, Gale BK, Carrell DT, Hotaling JM (2017). Separation of sperm cells from samples containing high concentrations of white blood cells using a spiral channel. Biomicrofluidics, 11(5), 054106.

73.

Hotaling JM (2017). DNA fragmentation: a skeptic sees a bright future. Transl Androl Urol, 6(Suppl 4), S334.

74.

Carrell DT, Hotaling J (2017). Using sperm testing to improve patient and offspring health: rational, evidence-based care of the infertile male in the ART clinic. Transl Androl Urol, 6(Suppl 4), S443-S445.

75.

Martin L, Mullaney S, Peche W, Peterson K, Chan S, Morton R, Wan Y, Zhang C, Presson AP, Emery B, Aston K, Jenkins T, Carrell D, Hotaling J (2017). Population-based Semen Analysis Results and Fertility Among Patients With Inflammatory Bowel Disease: Results From Subfertility Health Assisted Reproduction and the Environment (SHARE) Study. Urology, 107, 114-119.

76.

Palmer MR, Holt SK, Sarma AV, Dunn RL, Hotaling JM, Cleary PA, Braffett BH, Martin C, Herman WH, Jacobson AM, Wessells H (2017). Longitudinal Patterns of Occurrence and Remission of Erectile Dysfunction in Men With Type 1 Diabetes. J Sex Med, 14(10), 1187-1194.

77.

Oottamasathien S, Hotaling JM, Craig JR, Myers JB, Brant WO (2017). Amniotic therapeutic biomaterials in urology: current and future applications. Transl Androl Urol, 6(5), 943-950.

78.

Keihani S, Craig JR, Zhang C, Presson AP, Myers JB, Brant WO, Aston KI, Emery BR, Jenkins TG, Carrell DT, Hotaling JM (2017). Impacts of Abstinence Time on Semen Parameters in a Large Population-based Cohort of Subfertile Men. Urology, 108, 90-95.

79.

Guo J, Grow EJ, Yi C, Mlcochova H, Maher GJ, Lindskog C, Murphy PJ, Wike CL, Carrell DT, Goriely A, Hotaling JM, Cairns BR (2017). Chromatin and Single-Cell RNA-Seq Profiling Reveal Dynamic Signaling and Metabolic Transitions during Human Spermatogonial Stem Cell Development. Cell Stem Cell, 21(4), 533-546.e6.

80.

Martin L, Peche W, Peterson K, Wan Y, Chan S, Morton R, Zhang C, Presson AP, Hotaling J (2017). Population Based Paternity Rate and Partner Birth Outcomes Among Utah Men With Inflammatory Bowel Disease. Am J Gastroenterol, 112(11), 1722-1727.

81.

Jenkins TG, James ER, Alonso DF, Hoidal JR, Murphy PJ, Hotaling JM, Cairns BR, Carrell DT, Aston KI (2017). Cigarette smoking significantly alters sperm DNA methylation patterns. Andrology, 5(6), 1089-1099.

82.

Hotaling JM, Laufer N, Rosenwaks Z (2018). Introduction: Cancer biomarkers and fertility. Fertil Steril, 109(1), 4-5.

83.

Donnenfeld SR, Keihani S, Young JB, Majercik S, Hotaling JM, Myers JB (2018). The bull's-eye sign: A hallmark radiologic sign of complete ureteropelvic junction disruption after blunt renal trauma. Urol Case Rep, 17, 91-93.

84.

Keihani S, Xu Y, Presson AP, Hotaling JM, Nirula R, Piotrowski J, Dodgion CM, Black CM, Mukherjee K, Morris BJ, Majercik S, Smith BP, Schwartz I, Elliott SP, DeSoucy ES, Zakaluzny S, Thomsen PB, Erickson BA, Baradaran N, Breyer BN, Miller B, Santucci RA, Carrick MM, Hewitt T, Burks FN, Kocik JF, Askari R, Myers JB (2018). Contemporary management of high-grade renal trauma: Results from the American Association for the Surgery of Trauma Genitourinary Trauma study. J Trauma Acute Care Surg, 84(3), 418-425.

85.

Keihani S, Anderson RE, Fiander M, McFarland MM, Stoddard GJ, Hotaling JM, Myers JB (2018). Incidence of urinary extravasation and rate of ureteral stenting after high-grade renal trauma in adults: a meta-analysis. Transl Androl Urol, 7(Suppl 2), S169-S178.

86.

Spektor MS, Kellen D, Hotaling JM (2018). When the Good Looks Bad: An Experimental Exploration of the Repulsion Effect. Psychol Sci, 956797618779041.

87.

Alder NJ, Keihani S, Hotaling JM, Myers JB (2018). Management of blunt renal trauma in a crossed fused ectopic kidney. Urol Case Rep, 18, 38-40.

88.

Anderson RE, Hanson HA, Thai D, Zhang C, Presson AP, Aston KI, Carrell DT, Smith KR, Hotaling JM (2018). Do paternal semen parameters influence the birth weight or BMI of the offspring? A study from the Utah Population Database. J Assist Reprod Genet, 35(5), 793-799.

89.

Keihani S, Martin C, Craig JR, Zhang C, Presson AP, Myers JB, Aston KI, Emery BR, Carrell DT, Hotaling JM (2018). Semen parameters are unaffected by statin use in men evaluated for infertility. Andrologia, 50(5), e12995.

90.

Alder NJ, Keihani S, Stoddard GJ, Myers JB, Hotaling JM (2018). Combination therapy with clomiphene citrate and anastrozole is a safe and effective alternative for hypoandrogenic subfertile men.LID - 10.1111/bju.14390 [doi]. (Epub ahead of print) BJU Int.

91.

Patel DP, Williams L, Warner L, O'Neil ME, Aston K, Carrell DT, Grigorescu V, Jamieson DJ, Gannon JR, Eisenberg ML, Walsh TJ, Hotaling JM (2018). Use of secondary contraception following vasectomy: insights from the Pregnancy Risk Assessment Monitoring System, 2007-2011. Transl Androl Urol, 7(Suppl 3), S264-S270.

92.

Evans P, Keihani S, Breyer BN, Erickson BA, Hotaling JM, Lenherr SM, Myers JB (2018). A Prospective Study of Patient-reported Pain After Bulbar Urethroplasty. Urology, 117, 156-162.

93.

Hotaling JM, Ramasamy R (2018). Knowledge gaps in male fertility. Transl Androl Urol, 7(Suppl 3), S262-S263.

94.

Kane AC, Walvekar RR, Hotaling JM (2018). Transoral robotic resection of a retropharyngeal parathyroid adenoma: a case report.LID - 10.1007/s11701-018-0843-0 [doi]. (Epub ahead of print) Journal of Robotic Surgery.

95.

Patel B, Meeks H, Wan Y, Johnstone EB, Glenn M, Smith KR, Hotaling JM (2018). Transgenerational effects of chemotherapy: Both male and female children born to women exposed to chemotherapy have fewer children. Cancer Epidemiol, 56, 1-5.

96.

Keihani S, Hanson B, Hotaling JM (2018). Male factor infertility: an opportunity to investigate individual and family health.LID - 10.1111/1471-0528.15398 [doi]. (Epub ahead of print) BJOG.

97.

Patel B, Byrne JLB, Phillips A, Hotaling JM, Johnstone EB (2018). When standard genetic testing does not solve the mystery: a rare case of preimplantation genetic diagnosis for campomelic dysplasia in the setting of parental mosaicism. Fertil Steril, 110(4), 732-736.

98.

Moses RA, Keihani S, Craig JR, Basilius J, Hotaling JM, Lenherr SM, Brant WO, Myers JB (2018). Efficacy of Pressure Regulating Balloon Exchange in Men with Post Artificial Urinary Sphincter Persistent or Recurrent Stress Urinary Incontinence.LID - S0090-4295(18)30935-X [pii]LID - 10.1016/j.urology.2018.07.052 [doi]. (Epub ahead of print) Urology.

99.

Guo J, Grow EJ, Mlcochova H, Maher GJ, Lindskog C, Nie X, Guo Y, Takei Y, Yun J, Cai L, Kim R, Carrell DT, Goriely A, Hotaling JM, Cairns BR (2018). The adult human testis transcriptional cell atlas.LID - 10.1038/s41422-018-0099-2 [doi]. (Epub ahead of print) Cell Res.

100.

Jorgenson E, Matharu N, Palmer MR, Yin J, Shan J, Hoffmann TJ, Thai KK, Zhou X, Hotaling JM, Jarvik GP, Ahituv N, Wessells H, Van Den Eeden SK (2018). Genetic variation in the SIM1 locus is associated with erectile dysfunction. Proc Natl Acad Sci U S A, 115(43), 11018-11023.

NON PEER-REVIEWED JOURNAL ARTICLES

1.

Chapman KM, Medrano GA, Jaichander P, Chaudhary J, Waits AE, Nobrega MA, Hotaling JM, Ober C, Hamra FK (2015). Targeted Germline Modifications in Rats Using CRISPR/Cas9 and Spermatogonial Stem Cells. Cell Rep, 10(11), 1828-35.

2.

Anderson R, Hanson H, Aston KI, Carrell DT, Smith KR, Hotaling JM (2015). Cancer risk in first and second degree relatives of men with poor semen quality. Demography.

3.

Hotaling JM, Patel DP, Vendryes C, Lopushnyan NA, Presson AP, Zhang C, Muller CH, Walsh TJ (2016). Predictors of sperm recovery after cryopreservation in testicular cancer. Asian J Androl, 18(1), 35-8.

4.

Anderson R, Hotaling JM (2017). Improving US databases for male fertility. AUA News, 22(5), 10.

5.

Keihani S, Craig JR, Zhang C, Presson AP, Myers JB, Brant WO, Aston KI, Emery BR, Jenkins TG, Carrell DT, Hotaling JM (2018). Proton-pump inhibitor use does not affect semen quality in subfertile men. Asian J Androl, 20(3), 290-293.

REVIEW ARTICLES

1.

Hotaling JM, Walsh TJ (2009). Male infertility: a risk factor for testicular cancer. [Review]. Nat Rev Urol, 6(10), 550-6.

2.

Hotaling JM, Smith JF, Rosen M, Muller CH, Walsh TJ (2011). The relationship between isolated teratozoospermia and clinical pregnancy after in vitro fertilization with or without intracytoplasmic sperm injection: a systematic review and meta-analysis. [Review]. Fertil Steril, 95(3), 1141-5.

3.

Hotaling JM, Patel Z (2014). Male endocrine dysfunction. [Review]. Urol Clin North Am, 41(1), 39-53.

4.

Hotaling JM (2014). Genetics of male infertility. [Review]. Urol Clin North Am, 41(1), 1-17.

5.

Craig JR, Wallis C, Brant WO, Hotaling JM, Myers JB (2014). Management of adults with prior failed hypospadias surgery. [Review]. Transl Androl Urol, 3(2), 196-204.

6.

Trofimenko V, Hotaling JM (2016). Fertility treatment in spinal cord injury and other neurologic disease. [Review]. Transl Androl Urol, 5(1), 102-16.

7.

Patel DP, Chandrapal JC, Hotaling JM (2016). Hormone-Based Treatments in Subfertile Males. [Review]. Curr Urol Rep, 17(8), 56.

8.

Hanson B, Johnstone E, Dorais J, Silver B, Peterson CM, Hotaling J (2017). Female infertility, infertility-associated diagnoses, and comorbidities: a review. [Review]. J Assist Reprod Genet, 34(2), 167-177.

9.

Myers JB, Brant WO, Hotaling JN, Lenherr SM (2017). Urethral Strictures and Artificial Urinary Sphincter Placement. [Review]. Urol Clin North Am, 44(1), 93-103.

10.

Craig JR, Jenkins TG, Carrell DT, Hotaling JM (2017). Obesity, male infertility, and the sperm epigenome. [Review]. Fertil Steril, 107(4), 848-859.

11.

Patel DP, Craig JR Jr, Myers JB, Brant WO, Hotaling JM (2017). Serum Biomarkers of Erectile Dysfunction in Diabetes Mellitus: A Systematic Review of Current Literature. [Review]. Sex Med Rev, 5(3), 339-348.

12.

Oottamasathien S, Hotaling JM, Craig JR, Myers JB, Brant WO (2017). Amniotic therapeutic biomaterials in urology: current and future applications. [Review]. Transl Androl Urol, 6(5), 943-950.

13.

Hanson BM, Eisenberg ML, Hotaling JM (2018). Male infertility: a biomarker of individual and familial cancer risk. [Review]. Fertil Steril, 109(1), 6-19.

14.

Hanson BM, Aston KI, Jenkins TG, Carrell DT, Hotaling JM (2018). The impact of ejaculatory abstinence on semen analysis parameters: a systematic review. [Review]. J Assist Reprod Genet, 35(2), 213-220.

15.

Cardinal J, Slade A, McFarland M, Keihani S, Hotaling JN, Myers JB (2018). Scoping Review and Meta-analysis of Hyperbaric Oxygen Therapy for Radiation-Induced Hemorrhagic Cystitis. [Review]. Curr Urol Rep, 19(6), 38.

16.

Armstrong JM, Keihani S, Hotaling JM (2018). Use of Ultrasound in Male Infertility: Appropriate Selection of Men for Scrotal Ultrasound. [Review]. Curr Urol Rep, 19(8), 58.

17.

Hanson BM, Hotaling JM (2018). Limitations and opportunities in male fertility databases. [Review]. Transl Androl Urol, 7(Suppl 3), S292-S302.

18.

Anderson R, Moses R, Lenherr S, Hotaling JM, Myers J (2018). Spinal cord injury and male infertility-a review of current literature, knowledge gaps, and future research. [Review]. Transl Androl Urol, 7(Suppl 3), S373-S382.

BOOK CHAPTERS

1.

Broghammer J, Hotaling JM (2013). Traumatic Ureteral Injuries. In Wessells H (Ed.), Urologic Emergencies (2nd, pp. 39-53). Philadelphia: Springer.

2.

Hotaling J, Niederberger C (2014). Fertility and Cancer Therapy. In Gomella LG (Ed.), The 5-Minute Clinical Consult Urology (3rd). Philadelphia: Lippincott Williams & Wilkins.

3.

Jason Chandrapol and James Hotaling (2017). Genetic Testing of Y Chromosome Micro Deletion. In Nicolas Garrido Rocio Rivera (Ed.), Practical Guide to Sperm Analysis: Basic Andrology in Reproductive Medicine (pp. 37-52). CRC Press.

4.

Carrell DT, Jenkins TG, Emery BR, Hotaling JM, Aston KI (2018). The Role of Reproductive Genetics in Modern Andrology. In Palermo GD and Sills ES (Eds.), Intracytoplasmic Sperm Injection: Indications, Techniques and Applications (pp. 23-38). Springer.

5.

Sorena Keihani, Jeremy B. Myers, James M. Hotaling (2018). Spermatogenesis: Fertile Ground for Contributing to Recurrent Implantation Failure? In Jason F. Franasiak Richard T Scott (Ed.), Recurrent Implantation Failure Etiologies.

OTHER (Commentary/Letters/Editorials/Case Reports/Video/Film) 

Case Reports

1.

Hsi RS, Hotaling JM, Spencer ES, Bollyky PL, Walsh TJ (2011). Isolated infection of a decommissioned penile prosthesis reservoir with Actinomyces neuii. J Sex Med, 8(3), 923-6.

Editorials

1.

Hotaling (2013). Finasteride and male infertility: a case for prospective collaborative research databases? Fertil Steril, 100(6), 1528-1529.

2.

Hotaling JM, Aston KI, Carrell DT (2014). Refined phenotyping, large cohorts, and collaborative research are vital for realizing the potential of genomics to transform care for male infertility. Fertil Steril, 102(4), 967.

3.

Brant WO, Hotaling JM (2014). Is there still a role for primary realignment for stricture due to pelvic fracture? J Urol, 192(6), 1595-6.

4.

Myers JB, Brant WO, Hotaling JM (2015). Editorial comment. Urology, 85(1), 244-5.

5.

Hotaling JM, Jenkins TG (2015). MicroRNA: a step beyond bulk seminal parameters? Fertil Steril, 104(3), 554.

6.

Anderson RE, Hotaling JM (2015). Inherent difficulties of meta-analysis for surgical techniques in male infertility: an argument for standardizing reporting and outcomes. Fertil Steril, 104(5), 1127-8.

7.

Hotaling JM (2015). Global deoxyribonucleic acid methylation: a window into the spermatogonial stem cell's reproductive potential. Fertil Steril, 104(6), 1374-5.

8.

Schaeffer AJ, Hotaling JM (2016). Claims-based analysis of male infertility: a cautious step in the right direction. Fertil Steril, 105(3), 599-600.

9.

Johnstone EB, Hotaling JM (2016). Conservation of ovarian reserve across ethnicities: evidence of the evolutionary importance of maintenance of ovarian reserve. Fertil Steril, 106(2), 272.

10.

Jensen CF, Dupree JM, Sonksen J, Ohl D, Hotaling JM (2017). A call for standardized outcomes in microTESE. Andrology, 5(3), 403.

Letters

1.

Ohlander S, Hotaling J, Kirshenbaum E, Niederberger C, Eisenberg ML (2014). Use of fresh versus cryopreserved sperm [Letter to the editor]. Fertil Steril, 101(2), e12.

Other

1.

Hotaling J (2002). "An Attempted Synthesis of 1.2 Difluorocyclobutadine" Honors Thesis. Hanover, NH: Dartmouth College.

2.

Patel B, Johnstone EB, Presson A, Zhang C, Jenkins T, Aston KI, Carrell DT, Hotaling J (2016). The Effect of ADHD Medications on Semen Analysis In Sub-Fertile Couples. Poster selected for phone-in briefing for journalists prior to 72nd American Society for Reproductive Medicine 2016 Scientific Congress & Expo, Oct.10, Salt Lake City, UT.

Patents

1.

Hotaling JM (2014). Systems and Methods for Identifying Instruments. U.S. Patent No. App#61/80847. Washington, D.C.:U.S. Patent and Trademark Office.

2.

Hotaling JM (Published). Apparatus for Noninvasively Measuring Corporal Hemodynamic and Mechanical Parameters for the Diagnosis of Sexual Dysfunction in Men and Women. U.S. Patent No. App#14/102,504. Washington, D.C.:U.S. Patent and Trademark Office.

3.

Hotaling JM (2014). Telemicroscopy Device. U.S. Patent No. App#61/825361. Washington, D.C.:U.S. Patent and Trademark Office.

4.

Hotaling JM (2014). Sperm-DNA: An Automatic Algorithm for Sperm Cell Detection and Motility Analysis. U.S. Patent No. App#61/861701. Washington, D.C.:U.S. Patent and Trademark Office.

5.

Hotaling JM (Published). Systems and Methods for Monitoring Physiological Parameter of a Cyclist. U.S. Patent No. App#61/764696. Washington, D.C.:U.S. Patent and Trademark Office.

6.

Hotaling JM (2014). A Novel Circumcision Device. U.S. Patent No. App#61/722278. Washington, D.C.:U.S. Patent and Trademark Office.

7.

Hotaling JM (2015). Fluid Analysis Device and Associated Systems and Methods. U.S. Patent No. Patent S/N PCT/US2015/023364. Washington, D.C.:U.S. Patent and Trademark Office.

8.

Bruce K. Gale, Douglas T. Carrell, Kristin Murphy, Jim Hotaling, Jiyoung Son (2015). Tissue sample processing system and associated methods. U.S. Patent No. US15520795. Washington, D.C.:U.S. Patent and Trademark Office.

9.

Hotaling JM (2015). Inverse Tomographic Construction: A Non-Layered Construction Paradigm for Rapid Prototypin. U.S. Patent No. Patent S/N PCT/US2015/056494. Washington, D.C.:U.S. Patent and Trademark Office.

Video/Film/CD/Web/Podcast

1.

Kerr RR (2014). Infertility research explores linkage to all-cause mortality, psychiatric disorders. Expert resource: Hotaling jM [Web]. Urologytimes.modernmedicine.com.

2.

Office of Public Affairs (2014). Men's Myth Busters [Video]. Salt Lake City: University Of Utah. Available: http://healthcare.utah.edu/healthfeed/postings/2014/06/061214_mens-myth-busters.php.

3.

Hotaling JM (2014). High-volume surgeons show multiple options for IPP placement [Video]. Urologytimes.modernmedicine.com.

4.

Commentary by Hotaling JM (2014). Erectile dysfunction: Multiple treatment options. Edited by Brant WO and Trueheart K [Video]. UrologyTimes.com.

5.

Commentary by Hotaling JM (2014). 'Men's health' more than a marketing ploy. Edited by Kerr RR [Video]. Urolotytimes.modernmedicine.com.

6.

Hilton L (2014). Urologists helping driving male-specific centers: Men's health clinics bring needed care under one roof. Expert resource: Hotaling J [Web]. Urologytimes.modernmedicine.com.

7.

Hilton L, Iannetta A (2014). The University of Utah's men's health clinic (slideshow). Expert Resource: Hotaling JM [Web]. Urologytimes.modernmedicine.com.

8.

Commentary by Hotaling JM (2014). IPP: Semi-rigid prosthesis placed via subcoronal approach. Edited by Carrion R [Video]. UrologyTimes.com.

9.

Commentary by Hotaling JM (2014). IPP: Retractor-less approach to IPP placement. Edited by Walsh T [Video]. UrologyTimes.com.

10.

Commentary by Hotaling JH (2014). IPP: Ventral phalloplasty and IPP placement. Edited by Carrion R [Video]. UrologyTimes.com.

11.

Commentary by Hotaling JM (2014). IPP: Approaches to prosthesis an AUS placement. Edited by Jones L [Video]. UrologyTimes.com.

12.

Commentary by Hotaling JH (2014). IPP: Penoscrotl IPP placement with ventral phalloplasty. Edited by Carrion R [Video]. UrologyTimes.com.

13.

Hotaling J, Brant WO (2014). Let's Talk Men's Health: Alternatives to T therapy: Lessons from male infertility [Web]. Urologytimes.com, Nov, PP 18-20.

14.

Hotaling JM, Brant WO (2014). Alternatives to T therapy: Lessons from male infertility [Web]. Urologytimes.mondernmedicine.com.

15.

Kerr RR (2014). Study links sunscreen to impaired male fertility. Expert Resource: Hotaling JM [Web]. Urologytimes.modernmedicine.com.

16.

Hotaling JM (2015). Let's Talk Men's Health; How to conduct a cost-effective evaluation of the infertile male patient Thorough history/physical, high-quality semen analyses among critical components [Web]. Urologytimes.modernmedicine.com.

17.

Commentary by Hotaling JH (2015). Williams Vasectomy Reversal (epididymovasostomy) Video [Video]. UrologyTimes.com. Available: http://www.youtube.com/watch?v=AMc1_ntLbuw.

18.

Commentary: Hotaling JM (2015). Excision and Primary Anastomosis Anterior Urethroplasty. Editor: Myers J; [Video]. UrologyTimes.com.

19.

Hotaling JM (2015). The Device Will See You Now: Point of Care Diagnostic Devices in Urology [Web]. Urologytimes.modernmedicine.com.

20.

Commentary By Hotaling JM (2015). Varicocelectomy: Microsurgical, subinguinal technique. Edited By Goldstein M [Video]. UrologyTimes.com.

21.

Commentary by Hotaling JM (2015). Williams Vasectomy Reversal (vasovasostomy) Video [Video]. UrologyTimes.com. Available: http://www.youtube.com/watch?v=onePH0MF64Q.

22.

Hilton L (2015). Men's Health Matters; Expert Resource Hotaling JM [Web]. UrologyTimes.com.

23.

Commentary by Hotaling JM (2015). Vasectomy reversal: Microsurgical two-layer vasovasostomy. Edited by Karpman E [Video]. UrologyTimes.com. Available: https://www.youtube.com/watch?v=1kg619Fbw0Y.

24.

Saylor BP (2015). ICSI use doubles despite lack of improved outcomes. Expert resource: Hotaling JM [Web]. Urologytimes.modernmedicine.com.

25.

Commentary by Hotaling JM (2015). Urethroplasty: Posterior Urethroplasty for pelvic fracture urethral injury. Editor Myers J/ [Video]. UrologyTimes.com.

26.

Commentary by Hotaling JM (2015). Urethroplasty: Perineal Urethrostomy for Severe Urethral Strictures. Editor Myers J [Video]. UrologyTimes.com.

27.

Commentary Hotaling, JM (2015). Urethroplasty Bulbospongiosus Sparing Dorsal Onlay Bulbar Urethroplasty. Editor: Vanni A [Video]. UrologyTimes.com.

28.

Saylor BP (2015). FDA moves to change TRT product labeling. Expert Resource: Hotaling JM [Web]. Urologytimes.modernmedicine.com.

29.

Saylor BP (2015). State of Urology: Our experts' top picks for AUA 2015. Expert Resource Hotaling JM [Web]. Urologytimes.modernmedicine.com.

30.

Commentary by Hotaling JM (2015). Varicocelectomy: Single-port laparoscopic technique. Edited by Alukal J [Video]. Urologytimes.modernmedicine.com.

31.

Commentary by Hotaling JM (2015). Sperm extraction: Two percutaneous techniques. Edited by Hsieh TM [Video]. UrologyTimes.com.

32.

Commentary by Hotaling JM (2015). Sperm extraction: MicroTESE and multiphoton microscopy. Edited by Ramasamy R [Video]. UrologyTimes.com.

33.

Commentary by Hotaling JH (2015). Vasectomy: A different approach to isolating the vas. Edited by Williams DH [Video]. UrologyTimes.com.

34.

Commentary by Hotaling JM (2015). Vasectomy: Crucial steps for a bloodless procedure. Edited by Goldstein M, and Li PS [Video]. UrologyTimes.com.

35.

Hotaling JM (2000). Robotic Cystectomy with Neobladder; commentary from Dr. Dechet [Video]. UrologyTimes.com.

36.

Commentary by Hotaling JM (2016). Robotic cystectomy: Intracorporeal neobladder using studer technique. Edited by Santomauro MG [Video]. UrologyTimes.com.

37.

Commentary by Hotaling JM (2016). Robotic cystectomy: ileal conduit. Edited by Dechet CB [Video]. UrologyTimes.com.

38.

Commentary by Hotaling JM (2016). Robotic cystectomy: Y-shaped neobladder technique. Edited by Warner JN [Video]. UrologyTimes.com.

39.

Hotaling JM, Carrell DT (2016). Let's Talk Men's Health: Epigenetics and genetics: The future of cost-effective care? [Web]. Urologytimes.modernmedicine.com.

40.

Hilton L (2016). 'T' clinics create concerns about care, competition. Expert resource: Hotaling JM [Web]. Urologytimes.modernmedicine.com.

41.

Hotaling JM (2016). AUS placement: Key steps in the Duke technique. Edited by Paterson AC and Zaid UB [Video]. UrologyTimes.com.

42.

Saylor BP (2016). AUA 2016: Experts offer guidance on the meeting. Expert Resource Hotaling JM [Web]. Urologytimes.modernmedicine.com.

43.

Hilton L (2016). TTrials: T therapy improves sexual desire, activity. Expert resource: Hotaling JM [Web]. urologytimes.modernmedicine.com.

44.

Hilton, L (2016). Testosterone therapy improves 65-and-older men’s sex lives. Expert Resource: James Hotaling [Web]. Urology Times (enews).

45.

Hilton Lisette (2016). FDA adds new warning, updated labeling for T products. Expert resource: Hotaling JM [Web]. Urologytimes.modernmedicine.com.

46.

Craig JR, Brant WO, Hotaling JM (2016). "Men's Health Mythbuster" Does heat exposure affect spermatogenesis [Web]. Urologytimes.modernmedicine.com.

47.

Myers JB, Vanni A, Voelzke B, Witten J, Dugi D, Hotaling JM (2016). Buried penis repair: Videos illustrate aesthetic, functional considerations [Video]. Urologytimes.modernmedicine.com.

48.

Hotaling JM (2017). Experts Perspective: Sperm 101: How to Interpret the Semen Analysis [Web]. FertilityIQ. Available: https://www.fertilityiq.com/male-factor-infertility/sperm-101-how-to-interpret-the-semen-analysis.

49.

Baldwin DD, Ghani KR, Borofsky MS, Hotaling JM (2017). Ureteroscopy: Surgeons show techniques, tips in videos [Web]. Urologytimes.modernmedicine.com.

50.

Hilton L (2017). Take charge of your online reputation. Expert resource: Hotaling JM [Web]. Urologytimes.modernmedicine.com.

51.

Zhao L, Shi D, Groatas A Djordjevic ML. Dy GW, Hotaling JM (2017). Transgender surgery: Videos demonstrate cutting-edge techniques [Video]. Urologytimes.modernmedicine.com.

52.

Kerr RR (2017). AUA '17 puts ephasis squarelyon 'value'. Expert resource Hotaling JM [Web]. Urologytimes.modernmedicine.com.

53.

Craig J, Hotaling JM (2017). Cord denervation: Surgeons describe microsurgical techniques in men with scrotal pain [Video]. urologytimes.modernmedicine.com.

54.

Masterson TA, Ramasamy R, Hotaling JM (2017). Varicocele: Treatment indications and repair techniques [Web].

55.

Ellimoottil C (2017). "Tech talk with Jim and Steve" Video visits in urology: How clinicians, patients benefit [Web]. Urologytimes.modernmedicine.com.

56.

Hotling JM, Kaplan SA (2017). "Tech Talk with Jim and Steve" Tech advances catalyze paradigm shifts in patient care [Web]. urologytimes.modernmedicine.com.

57.

Ramasamy R, Hotaling JM (2017). Urologists illustrate key steps in management of duct obstruction [Video]. Urologytimes.modernmedicine.com.

58.

James M. Hotaling (06/05/2018). 12 Things You Should Know About Your Guy's Fertility [Web]. health.com. Available: http://www.health.com/infertility/male-infertility.

PENDING PUBLICATIONS 

Journal Articles

1.

Joseph M. Armstrong, Sorena Keihani, James M. Hotaling (pending). Use of Ultrasound in Male Infertility: Appropriate Selection of Men for Scrotal Ultrasound. Curr Urol Rep.

2.

Son J, Samuel R, Gale BK, Carrell DT, Hotaling JM (In Press). Separation Of Sperm Cells From Samples Containing High Concentrations Of White Blood Cells Using A Spiral Channel. Biomicrofluidics.

3.

Gui J, Grow EJ, Yi C, Murphy PJ, Wike CL, Carrell DT, Hotaling JM, Cairns BR (In Press). Transcription, signaling and metabolic transitions during human spermatogonial stem cell differentiation. Cell Stem Cell.

4.

Sorena Keihani MD, Brent Hanson, MD and James M. Hotaling MD (pending). Male Factor Infertility: A window into individual and familial health. Br J Obstet Gynaecol.

Book Chapters

1.

Biren V. Patel1, James M. Hotaling2 (Pending). Genomics and Epigenetics. In Drs. Ralf Henkel, Luna Samanta and Ashok Agarwal (Eds.), Oxidants, Antioxidants and the Impact of the Oxidative Status in Male Reproduction. Elsevier.

2.

Yetunde Ibrahim and James Hotaling (pending). Sperm Epigenetics and its Impact on Male Fertility, Pregnancy Loss and Somatic Health of Future Offspring. In Seminar in Reproductive Medicine.

3.

Kelley Taylor ARNP, James Hotaling MD MS FECSM (Pending). A Men’s Health Clinic Exemplar: Experience at the University of Utah. In Susanna Quallich (Ed.), The Nurse Practitioner in Urology: Men’s Health. Springer.

4.

Brent Hanson and James Hotaling (In Press). Inflammation and Men's Health. In Faysal A. Yafi (Ed.), The Effects of Lifestyle on Men's Health.

5.

Biren V. Patel, MD1 and James M. Hotaling, MD2 (In Press). Identified Epigenetic Effects. In Prof. Bernard Jégou & Prof. Michael Skinner (Eds.), Encyclopedia of Male Reproduction (4B-Reproductive Medicine: Male "Genetics", 1).

6.

Brent M. Hanson and James M. Hotaling (In Press). Male Infertility As A Marker Of Future Health. In EMERGING TOPICS IN REPRODUCTION (5, pp. 1-21). Springer.

7.

Patel DP, Hotaling JM, Niederberger CS (In Press). Azoospermia-Obstruction. In Case Studies In Male Infertility.

8.

Y. Ibrahim and J. Hotaling (In Press). Numerical chromosomal abnormalities. In Prof. Bernard Jégou & Prof. Michael Skinner (Eds.), Encyclopedia of male reproduction; (4B-Reproductive Medicine: Male "Genetics", 1).

9.

Brent Hanson and James Hotaling (In Press). Comorbidities associated with male infertility. In Prof. Bernard Jégou & Prof. Michael Skinner (Eds.), Encyclopedia of Male Reproduction (4B-Reproductive Medicine: Male "Genetics", 1).

RECENTLY PUBLISHED ABSTRACTS (Last 3 Years)

1.

Hotaling JM, Chow V, Zini A, Spitz A, Fischer MA, Zeitlin S, Sandlow J, Brannigan R, Goldstein M, Smith J, Ko E, Jarvi K (2016). Infertility: Epidemiology & Evaluation [Abstract]. American Association of Urology, Sand Diego, CA

2.

Anderson R, Hanson H, Aston KI, Carrell D, Smith K, Hotaling JM (2016). P9-36: Cancer Risk in First and Second Degree Relatives of Men with Poor Semen Quality [Abstract]. Population Association of America Annual Meeting, Washington, D.C

3.

Jarvi K, Lau S, Lo K, Grober E, Hotaling JM, Chow V, Zini A, Spitz A, Fischer MA, Zeitlin S, Fuchs E, Samplaski M, Sandlow J, Brannigan R, Goldstein M, Smith JF, Ko E (2016). First Report from the Andrology Research Consortium. Presented at the Annual Meeting of the American Urologic Association, New Orleans, LA, May 6 [Abstract]. Journal of Urology, 195(4S), e1160. 

4.

Anderson R, Hanson H, Oottamasathien S, Redshaw J, Schaeffer A, Johnstone EB, Aston KI, Carrell DT, Lowrance W, Smith K, Cartwright P, Hotaling JM (2016). Childhood Cancer Risk In The Siblings and Cousins Of Men With Poor Semen Quality. Prize Abstract. Presented at the 64th Annual Meeting of the Society for Pediatric Urology, San Diego, CA, May 6-8 [Abstract]. 

5.

Son J, Gale B, Samuel R, Jafek A, Jenkins TG, Hotaling J, Carrell DT (2016). Purification of sperm from high WBC semen sample using a spiral channel [Abstract]. MicroTAS 2016: The 20th International Conference on Miniaturized Systems for Chemistry and Life Sciences, Dublin, Ireland, October 9-13

6.

Patel B, Johnstone EB, Presson A, Zhang C, Jenkins T, Aston KI, Carrell DT, Hotaling JM (2016). The Effect of ADHD Medications on Semen Analysis in Sub-Fertile Couples. 72nd American Society for Reproductive Medicine 2016 Scientific Congress & Expo, Oct.15-19, Salt Lake City, UT [Abstract]. Fert & Steril, 106(3S), 197. 

7.

Jenkins T, Carrell DT, Hotaling J, Aston KI (2016). Cigarette Smoking and Associated Effects on the Rate of Aging in Sperm DNA Methylation Patterns. 72nd American Society for Reproductive Medicine 2016 Scientific Congress & Expo, Oct.15-19, Salt Lake City, UT [Abstract]. Fert & Steril, 106(3S), 198. 

8.

Johnstone EB, Link M, Patel B, Hotaling JM, Moore AK, Dorais J, Carrell DT, Peterson CM, Aston KI (2016). Does Outcome of the First IVF Cycle Allow Selection of Candidates for Repeat IVF Prior to PGS? 72nd American Society for Reproductive Medicine 2016 Scientific Congress & Expo, Oct.15-19, Salt Lake City, UT [Abstract]. Fert & Steril, 106(3S), 184. 

9.

Tam M, Brant WO, Oottamasathien S, Myers J, Hotaling JM (2016). Use of Amniotic Membrane In Benign Urology: A Novel Solution For Optimal Wound Healing. Western Section, American Urological Association’s 92 Annual Meeting, Kauai, HI, Oct. 23-28 [Abstract]. 

10.

Patel DP, Myers JB, Brant WO, Aston KI, Carrell DT, Hotaling JM (2016). Recent Exogenous Testosterone Use Among Men Presenting for Infertility Evaluation. Western Section, American Urological Association’s 92 Annual Meeting, Kauai, HI, Oct. 23-28 [Abstract]. 

11.

Pathak P, Chandrapal JC, Redshaw J, Hotaling JM, Lenherr S, Brant WO, Myers JB (2016). Outcomes And Morbidity Of Right Colon Pouch Urinary Diversion: A Single Center Retrospective Case Series. Western Section, American Urological Association’s 92 Annual Meeting, Kauai, HI, Oct. 23-28 [Abstract]. 

12.

Hanson HA, Pathak Piyush, Taddie M, Mayer EN, Smith KR, Vanderslice J, Hotaling JM, Lowrance WT (2016). Prostate Cancer: How and When Does Geography Matter? Western Section, American Urological Association’s 92 Annual Meeting, Kauai, HI, Oct. 23-28 [Abstract]. 

13.

Pathak P, Lenherr S, Hotaling JM, Brant WO, Myers JB (2016). Treatment of Urethral Stricture Disease With Direct Vision Internal Urethrotomy and Pentoxifylline Injection. Western Section, American Urological Association’s 92 Annual Meeting, Kauai, HI, Oct. 23-28 [Abstract]. 

14.

Presson A, Trofimenko V, Zhang C, Hanson HA, Smith KR, Carrell DT, Aston KI, Hotaling JM (2016). Seasonal Variation in Male Fertility Measures and Corresponding Birth Patterns. Western Section, American Urological Association’s 92 Annual Meeting, Kauai, HI, Oct. 23-28 [Abstract]. 

15.

Piyush P, Chandrapal JC, Erickson B, Elliot S, Levy ME, Voelzke B, Lenherr S, Hotaling JM, Brant WO, Meyers JB (2016). Use Of Continent Catheterizable Ileal Cecocystoplasty For The Treatment of Devastated Lower Urinary Tract Outlet. Western Section, American Urological Association’s 92 Annual Meeting, Kauai, HI, Oct. 23-28 [Abstract]. 

16.

Jenkins T, Aston K, Hotaling J, Carrell DT (2017). The impact of grand paternal aging on sperm DNA methylation patterns [Abstract]. 42nd Annual conference for the American Society of Andrology, Miami, FL, April 21-25

17.

Pathak P, Hanson H, Anderson R, Lowrance W, Smith K, Aston KI, Carrell DT, Hotaling JM (2017). Sex-specific thyroid cancer and melanoma risk in relatives of men with poor semen quality [Abstract]. Annual Meeting of the American Urological Association, Boston, MA, May 12-16

18.

Hotaling JM (2017). The back-up vasectomy reversal. Testicular sperm extraction at the time of vasectomy reversal in the couple with advanced maternal age: a cost-effectiveness analysis [Abstract]. Annual Meeting of the American Urological Association, Boston, MA, May 12-16

19.

James E, Jenkins T, Alonso D, Hotaling J, Carrell DT, Aston KI (2017). Sperm DNA methylation and epigenetic variability in tobacco smokers [Abstract]. At the Annual Meeting of the American Society of Andrology, Miami FL, May 12-16

20.

Hotaling JM (2017). Subfertility Health Assisted Reproduction and the Environment (SHARE): Trans-generational impacts of male infertility [Abstract]. Early Career Investigator Showcase Top Presentation at the Annual Meeting of the American Urologic Association, Boston, MA, May 12-16

21.

Society for the Study of Male Reproduction Andrology Research Consortium (2017). Results of a North American survey on the characteristics of men being assessed in male infertility clinics: the Andrology Research Consortium [Abstract]. Annual Meeting of the American Urological Association, Boston, MA, May 12-16

22.

Keihani S, Craig JF, Zhang C, Presson AP, Myers JB, Brant WO, Aston KI, Emery BR, Carrell DT, Hotaling JM (2017). Proton-pump inhibitor use and semen quality in subfertile men: is there a harmful effect? [Abstract]. Annual Meeting of the American Urological Association, Boston, MA, May 12-16

23.

Martin L, Peche W, Peterson K, Chan S, Morton R, Wan Yuan, Emery BR, Aston KI, Jenkins T, Presson A, Zhang C, Carrell DT, Hotaling JM (2017). Population-based semen analysis results among patients with inflammatory bowel disease [Abstract]. Annual Meeting of the American Society of Andrology, Miami FL, May 12-16

24.

Craig JR, Keihani S, Zhang C, Presson AP, Myers JB, Brant JO, Aston KI, Emery BR, Jenkins TJ, Carrell DT, Hotaling JM (2017). Impact of abstinence time on semen parameters in a large population based cohort of subfertile men [Abstract]. Annual Meeting of the American Urological Association, Boston, MA, May 12-16

25.

Jorgenson E, Palmer MR, Yin J, Shan J, Hotaling JM, Wessells H, Van Den Eeeden SK (2017). Erectile Dysfunction Genomics (EDGE): A GWAS of Erectile Dysfunction in the Kaiser Permanente of Northern California (KPNC) Genetic Epidemiology Research on Aging (GERA) Cohort [Abstract]. 2017 Annual Fall Scientific Meeting of the Sexual Medicine Society of North America, San Antonio, TX, October 26-29

26.

Patel B, Meeks H, Wan Y, Johnstone EB, Glenn M, Hotaling JM, Smith KR (2017). Children of men exposed to chemotherapy have normal fecundity [Abstract]. Scientific Congress of the American Society for Reproductive Medicine, San Antonio, TX, Oct 28-Nov 1

27.

Morin SJ, Juneau CR, Neal SA, Landis JN, Scott RT, Hotaling JM (2017). Comparison of the relative efficiency of ICSI and extended culture with epididymal sperm versus testicular sperm in patients with obstructive azoospermia [Abstract]. Scientific Congress of the American Society for Reproductive Medicine, San Antonio, TX, Oct 28-Nov 1

28.

Morin SJ, Juneau CR, Neal SA, Scott RT, Hotaling JM (2017). Total motile sperm count is negatively correlated with fertilization rate but not blastulation, euploidy, or implantation in ICSI cycles [Abstract]. Scientific Congress of the American Society for Reproductive Medicine, San Antonio, TX, Oct 28-Nov 1

29.

Jenkins T, Samuel R, Jafek A, Feng H, Gale B, Carrell DT, Hotaling JM (2017). Rapid microfluidic sperm isolation from microTESE samples in men with non-obstructive azoospermia [Abstract]. Scientific Congress of the American Society for Reproductive Medicine, San Antonio, TX, Oct 28-Nov 1

30.

Patel, B, Meeks H, Wan Y, Johnstone EB, Glenn M, Smith KR, Hotaling JM (2017). Intergenerational effects of chemotherapy on fecundity: Both male and female children born to women exposed to chemotherapy have fewer children [Abstract]. Scientific Congress of the American Society for Reproductive Medicine, San Antonio, TX, Oct 28-Nov 1

31.

Karandeep Singh*, Aruna V. Sarma, Rodney L. Dunn, Ann Arbor, MI, Sarah K. Holt, Seattle, WA, Hotaling, JM, Salt Lake City, UT, Rodica Pop-Busui, WilliamHerman, Ann Arbor, MI, Alan M. Jacobson, Mineola, NY, Barbara H. Braffett, Rockville, MD, Hunter Wessells, Seattle, WA, for the DCCT/EDIC Research Group, Rockville, MD (2018). Trajectories of Erectile Dysfunction Subphenotypes in Men with Longstanding Type I Diabetes. American Urological Association, San Francisco, CA, May 17-May 22 [Abstract]. 

32.

Karandeep Singh*, Ann Arbor, MI, Hunter Wessells, Seattle, WA, J. Quentin Clemens, Rodney L. Dunn, Ann Arbor, MI, Sarah K. Holt, Seattle, WA, JamesHotaling, Salt Lake City, UT, Rodica Pop-Busui, William Herman, Ann Arbor, MI, Alan M. Jacobson, Mineola, NY, Barbara H. Braffett, Rockville, MD, Aruna V.Sarma, Ann Arbor, MI, for the DCCT/EDIC Research Group, Rockville, MD (2018). Longitudinal Subphenotypes of Urinary Symptoms in Type I Diabetes. American Urological Association, San Francisco, CA, May 17-May 22 [Abstract]. 

33.

Nnenaya Agochukwu*, Bahaa Malaeb, Ann Arbor, MI, Hunter Wessells, Seattle, WA, James Hotaling, Salt Lake City, UT, Barbara Braffett, Washington, DC, Rodney Dunn, Ann Arbor, MI, Sarah Holt, Seattle, WA, Rodica Pop-Busui, William Herman, Ann Arbor, MI, Alan Jacobsen, Mineola, NY, Aruna Sarma, Ann Arbor, MI (2018). Orgasmic and Erectile Dysfunction in Men with Longstanding Type 1 Diabetes. American Urological Association, San Francisco, CA, MAy 17-May 22 [Abstract]. 

34.

Andrology Research Consortium (2018). Results of a North American survey on the characteristics of men presenting for infertility investigations: The Andrology Research Consortium [Abstract]. Annual Meeting of the American Urological Association, May 18

35.

Nnenaya Agochukwu, Bahaa Malaeb, Hunter Wessells, James Hotaling, Barbara Braffett, Rodney Dunn, Sarah Holt, Rodica Pop-Busui, James M. Hotaling (4/2018). Orgasmic and Erectile Dysfunction in Men with Longstanging Type I Diabetes [Abstract]. Annual Meeting of the American Urological Association, SanFrancisco, CA, May, 199(4), 1128-1129. 

36.

Rachel A. Moses, MD, MPH, James R. Craig, MD, Sorena Keihani, MD, Jeremy B. Myers, MD, Sara M. Lenherr, MD, MS, William O. Brant, MD, James M. Hotaling, MD, MS (4/2018). Erectile Dysfunction Management After Failed Phosphodiesterase 5-Inhibitor Trail: A Cost-Effectiveness Analysis [Abstract]. Annual Meeting of the American Urological Association, SanFrancisco, CA, May, 199(4), e558. 

37.

Darshan Patel, Kent Ogden, William Anderl, Suzette Mastrangelo, Alvin Le, James Hotaling, Stephen Summers (4/2018). Non-Inferiority of a Novel Capacitance Fluid Height Design Compared to Rotating Disc and Weight Transducer Designs for Home Uroflometry Applications [Abstract]. Annual Meeting of the American Urological Association, SanFrancisco, CA, May, 199(4), 972. 

38.

Sorena Keihani, Rachel Moses, Jeremy Myers, James Hotaling (4/2018). Baseline Body Mass Index and Estradiol Levels Predict Combination Therapy With Anastrozole In Hypogonadal Men Treated with Clomiphene Citrate [Abstract]. Annual Meeting of the American Urological Association, SanFrancisco, CA, May, 199(4), e88. 

39.

Biren Patel, Huong Meeks, Yuan Wan, Erica B. Johnstone, Martha Glenn, Darshan P. Patel, Ken Smith, James M. Hotaling (4/2018). Bipolar Disorder Seen At Higher Rate in the Offspring of Men Exposed tp Chemotherapy [Abstract]. Annual Meeting of the American Urological Association, SanFrancisco, CA, May, 199(4), e244. 

40.

Karandeep Singh, Hunter Wessells, J. Quentin Clemens, Rodney L. Dunn, Sarah K. Holt, James Hotaling, Rodica Pop-Busui, William Herman (4/2018). Longitudinal Subphenotypes of Urinary Symptoms in Type I Diabetes [Abstract]. Annual Meeting of the American Urological Association, SanFrancisco, CA, May, 199(4), 31-31. 

41.

Sorena Keihani, Rachel Moses, Yizhe Xu, Bryn Putbrese, Douglas Rogers, Xian Luo-Owen, Kaushik Mukherjee, Bradley Morris, James M Hotaling (4/2018). Imaging Findings Assopciated With Renal Bleeding Interventions After High-Grade Renal Trauma: Results From the American Assoication for Surgery of Trauma (AAST) Genito-Urinary Trauma Study [Abstract]. Annual Meeting of the American Urological Association, SanFrancisco, CA, May, 199(4), e333-334. 

42.

Keith Jarvi, Susan Lau, Kirk Lo, Ethan Grober, J.C. Trussell, James Hotaling, Thomas Walsh, Peter Kolettis, James M. Hotaling (4/2018). Results of a North American Survey on the Characteristics of Men Presenting for Infertility Investigation: The Andrology Research Consortium [Abstract]. Annual Meeting of the American Urological Association, SanFrancisco, CA, May, 199(4), 247. 

43.

Patrick Evans, Sorena Keihani, Benjamin Breyer, Bradley Erickson, James Hotaling, Sara Lenherr, Jeremy Myers (4/2018). A Prospective Study of Patient-Reported Pain After Bulbar Urethroplasty. Presented at the Annual Meeting of the American Urological Association, SanFrancisco, CA, May [Abstract]. Urology, 199(4), 637-638. 

44.

Sorena Keihani, Darshan Patel, Bryn Putbrese, Douglas Rogers, Xian Luo-Owen, Kaushik Mukherjee, Bradley Morris, Sarah Majercik, James M. Hotaling (4/2018). The Importance Of The Timinig Of Excretory Phase CT Scan In The Diagnosis Of Urinary Extravasation After High-Grade REnal Trauma [Abstract]. Annual Meeting of the American Urological Association, SanFrancisco, CA, May, 199(4), e68. 

45.

Karandeep Singh, Aruna V. Sarma, Rodney L. Dunn, Sarah K. Holt, James Hotaling, Rodica Pop-Busui, William Herman, Alan M. Jacobson, James m. Hotaling (4/2018). Trajectories of Erectile Dysfunction Subphenotypes in Men with Longstanging Type I Diabetes [Abstract]. Annual Meeting of the American Urological Association, SanFrancisco, CA, May, 199(4), 1006. 

46.

Keihani S, Moses RA, Zhang C, Presson AP, Smith KR, Carrell DT, Hanson H, Hotaling JM (2018). Ability of Semen Analysis To Predict The 5-year Probability of Fathering A Child. Presented at the 74Th American Society for Reproductive Medicine Scientific Congress & Expo, Denver, CO, Oct 6-10 [Abstract]. 

47.

Teigs AW, Landis J, Garrido N, Scott R, Hotaling JM (2018). Total Motile Sperm Count Trend Over Time Across Two Continents: Evaluation of Semen Analyses From 119,972 Infertile Men. Presented at the 74th American Society for Reproductive Medicine Scientific Congress & Expo, Denver, CO, Oct 6-10 [Abstract]. 

48.

Guo J, Grow EJ, Carrell DT, Hotaling JM, Cairns B (2018). The Adult Human Testis Cell Atlas Via Single Cell RNA Sequencing [Abstract]. 

49.

Slade A, Keihani S, Brant WO, Hotaling JM (2018). Stretcched Penile Length and Infertility, A New Asociation. Presented at the 74th American Socieity for Reproductive Medicine Scientific Congress & Expo, Denver, CO, Oct 6-10 [Abstract]. 

50.

Hanson B, Hawkins C, Stark L, Hotaling JM, Mehta A (2018). Qualitative Analysis of Male Partner Needs In Infertile Couples. Presented at the 74th American Socieity of Reproductive Medicine Scientific Congress & Expo, Denver, CO Oct 6-10 [Abstract]. 

UNPUBLISHED POSTER PRESENTATIONS

1.

Craig JR, Foss W, Hotaling JM, Brant WO (2016). Use Of Dehydrated Amniotic Membrane Allograft At The Time Of Microscopic Denervation Of The Spermatic Cord For Chronic Orchalgia Improves Outcomes. Poster session presented at 2016 Annual Fall Scientific Meeting of the Sexual Medicine Society of North America, Scottsdale, AZ, Nov 3-6.

2.

Basilius J, Redshaw J, Foss W, Craig J, Hotaling JM, Myers JB, Brant WO (2016). Scrotal Pain After Microsurgical Denervation Of The Spermatic Cord: Patient Reported Quality Of Life Outcomes. Poster session presented at 2016 Annual Fall Scientific Meeting of the Sexual Medicine Society of North America, Scottsdale, AZ, Nov. 3-6.

3.

Anderson RE, Hotaling JM, Myers JB, Brant WO (2016). Surgical Management And Outcomes Of Congenital Chordee In Adults. Poster session presented at 2016 Annual Fall Scientific Meeting of the Sexual Medicine Society of North America, Scottsdale, AZ, Nov. 3-6.

4.

Martin L, Peche W, Peterson K, Chan S, Morton R, Wan Y, Emery B, Aston KI, Jenkins T, Presson A, Zhang C, Carrell D, Hotaling J (2017). Population-based semen analysis results and fertility among men with inflammatory bowel disease: Results from Subfertility Health Assisted Reproduction and the Environment (SHARE) study. Poster session presented at Utah Chapter Meeting of the American College of Surgeons, Salt Lake City, May 11.

5.

Alder, N,  Keihani, S, Myers, J, Hotaling, J (October 2017). Outcomes of Combination Therapy with Clomiphene and Anastrozole in Subfertile Hypoandrogenic Men. Poster session presented at 18th Annual Fall Scientific Meeting of SMSNA, San Antonio.

6.

Rachel A. Moses MD, MPH, Sorena Keihani MD, Sarah Majercik* MD, Frank N. Burks MD, SeanP. Elliott MD, Kaushik Mukherjee* MD, Bradley A. Erickson MD, Richard A. Santucci MD, BrianP. Smith* MD, Christopher M. Dodgion* MD, MPH, Scott A. Zakaluzny* MD, Benjamin N. BreyerMD, James M. Hotaling MD, Raminder Nirula* MD, MPH, Jeremy B. Myers MD (09/28/2018). Current Management Of Extraperitoneal Traumatic Blader Injuries: Results From The American Association For The Surgery of Trauma (AAST) Genitourinary Trauma Study. Poster session presented at AAST Annual Fall Meeting, San Diego, CA..

7.

Sorena Keihani MD, Douglas M. Rogers MD, Bryn E. Putbrese MD, Kaushik Mukherjee* MD, Sarah Majercik* MD, Christopher M. Dodgion* MD, MPH, Scott A. Zakaluzny* MD, Brian P. Smith* MD, Jurek F. Kocik* MD, MatthewM. Carrick* MD, Reza Askari* MD, Angela P. Presson Ph.D., James M. Hotaling MD, Raminder Nirula* MD, MPH, Jeremy B. Myers M (09/28/2018). A NOMOGRAM PREDICTING THE NEED FOR BLEEDING INTERVENTIONS AFTER HIGH-GRADE
RENAL TRAUMA: RESULTS FROM THE AMERICAN ASSOCIATION FOR THE SURGERY OF
TRAUMA (AAST GENITOURINARY TRAUMA STUDY.
Poster session presented at AAST Annual Fall Meeting, San Diego, CA.

ORAL PRESENTATIONS 

Meeting Presentations (Not Published Abstracts and Not Unpublished Posters)

National

2014 

An Update on Epididymovasostomy Indications and Technique. American Society for Reproductive Medicine Annual Meeting Lunch With The Experts, Honolulu HI, Oct 17-23. 

2015 

Male Infertility and Comorbidities: Improving Male Health Through Proper Evaluation. American Society for Reproductive Medicine Annual Meeting, Lunch With The Experts, Baltimore MD, Oct 17-23. 

2015 

Moderator, State of Urology 2015 poster session, American Urological Association Annual Meeting, New Orleans LA, May . 

2016 

Post-Vasectomy Pain Syndrome: Epidemiology, Evaluation and Treatment. Annual Meeting of the American Urological Association Society for the Study of Male Reproduction (SSMR), San Diego CA, May 8. 

2016 

Biomarkers of Erectile Dysfunction. 2016 Annual Fall Scienfific Meeting of the Sexual Medicine Society of North America, Scottsdale, AZ, Nov 3-6. 

2016 

Oncofertility. 2016 Annual Fall Scientific Meeting of the Sexual Medicine Society of North America, Scottsdale, AZ, Nov 3-6. 

2016 

Invited Moderator: Erectile Dysfunction Epidemiology and Medical. 2016 Annual Fall Scientific Meeting of the Sexual Medicine Society of North America, Scottsdale, AZ, Nov 3-6. 

2016 

Moderator: Sexual Medicine. 2016 Annual Fall Scientific Meeting of the Sexual Medicine Society of North America, Scottsdale, AZ, Nov 3-6. 

2017 

Creating a successful men's health center - an evidence based approach. Presented at the Annual Meeting of the American Urological Association, Boston MA, May 12-16. 

2017 

Profiling of human adult spermatogonial stem cells reveals transcription and signaling programs for self renewal and differentiation. Presented at the Annual Meeting of the American Urologic Association, Boston, MA, May 12-16. 

2017 

Subfertility Health Assisted Reproduction and the Environment (SHARE): Trans-generational impacts of male infertility. Presented for the Rising Star Award at the Annual Meeting of the American Urologic Association, Boston MA, May 12-16. 

2017 

Results of a North American survey on the characteristics of men being assessed in male infertility clinics: the Andrology Research Consortium. Presented at the Annual Meeting of the American Urologic Association, Boston, MA, May 12-16. 

2017 

Erectile Dysfunction Genomics (EDGE): A GWAS of Erectile Dysfunction in the Kaiser Permanente of Northern California (KPNC) Genetic Epidemiology Research on Aging (GERA) Cohort. 18th Annual Fall Scientific Meeting of SMSNA. San Antonio, TX, Oct. 26-29. 

2017 

Round table moderator: Update on Culturing Human Spermatogonial Stem Cells for Oncofertility. Annual meeting of the American Society for Reproductive Medicine. San Antonio, TX. Oct 30. 

2017 

Oral abstract session: Male Reproduction and Urology. Annual meeting of the American Society of Reproductive Medicine. San Antonio,TX, Oct. 30 

Local/Regional

 

2016 

Seasonal Variation In Male Fertility Measures And Corresponding Birth Patterns. Western Section of the American Urologic Association, Kauai, HI, Oct. 23-28. 

2016 

Use Of Continent Catheterizable Ileal Cecocystoplasty For The Treatment Of Devastated Lower Urinary Tract Outlet. Western Section of the American Urologic Association, Kauai, HI, Oct. 23-28. 

2016 

Treatment of Urethral Stricture Disease With Direct Vision Internal Urethrotomy And Pentoxifylline Injection. Western Section of the American Urologic Association, Kauai, HI, Oct. 23-28. 

2016 

Prostate Cancer: How And When Does Geography Matter? Western Section of the American Urologic Association, Kauai, HI, Oct. 23-28. 

2016 

Use of Amniotic Membrane in Benign Urology: A Novel Solution For Optimal Wound Healing. Western Section of the American Urologic Association, Kauai, HI, Oct. 23-28. 

2016 

Recent Exogenous Testosterone Use Among Men Presenting For Infertility Evaluation. Western Section of the American Urologic Association, Kauai, HI, Oct. 23-28. 

2017 

StreamDx Urine Flowmeter. University of Utah Translational Medicine Symposium 2017, Salt Lake City, UT, Feb. 27. 

2017 

"Male Infertility: Counseling & Referral for the REI" at the Pacific Coast Reproductive Society, Palm Springs, CA, March 21-25 

2017 

"Male Infertility" at the Pacific Coast Reproductive Society, Palm Springs, CA, March 21-25 

2017 

Male Infertility- A Comprehensive Update. 65th Annual Meeting of the Pacific Coast Reproductive Society, Indian Wells CA, March 22-26. 

2017 

The Medical Treatment of Idiopathic Oligospermia and Unexplained Male Infertility Update. 65th Annual Meeting of the Pacific Coast Reproductive Society, Indian Wells CA, March 22-26. 

Invited/Visiting Professor Presentations

International

2018 

Male Infertility & Somatic Health: Nature or Nurture? UAE Reproductive Symposium Fertility Forward 2018. Dubai, March 23-24. 

National

 

2013 

Hotaling J, Eisenberg M, Rao P, Ross L. Use of a novel electronic medical record to study male infertility. Invited Presentation to the Center for Disease Control (CDC) Working Group on Men's Health, Atlanta, GA, August 

2016 

The Spermatogonial Stem Cell: A biomarker of male infertility & Somatic Health. RAMANJ January 21 

2016 

Male Infertility: A biomarker for cancer risk? Rutgers University, Camden, NJ, January 21 

2017 

Male Infertility. At Frontiers in Reproductive Endocrinology. Arlington, VA, March 2-5. 

2017 

"Breakout Session I: Transitioning From Residency to Fellowship" at the Society for Reproductive Endocrinology & Infertility (SREI) Annual Fellow Retreat, Park City, UT, Aug 10 

2017 

"Breakout Session II: Developing Your Own Priorities for Fellowship" at the Society for Reproductive Endocrinology & Infertility (SREI) Annual Fellow Retreat, Park City, UT, Aug 10 

2017 

Male Infertility: Counseling & Referral for the REI" at the Society for Reproductive Endocrinology & Infertility (SREI) Annual Fellow Retreat, Park City, UT, Aug 10 

2017 

Efficiency & Academic Success: Educational Tools" at the Society for Reproductive Endocrinology & Infertility (SREI) Annual Fellow Retreat, Park City, UT, Aug 11 

2017 

"Breakout Session V: Your Research and Thesis" at the Society for Reproductive Endocrinology & Infertility (SREI) Annual Fellow Retreat, Park City, UT, Aug 12 

2017 

Health Risks & Male Infertility: Towards an Ideal Database" NIH Symposium on Andrology, Rockville, MD, Aug 25 

2017 

"Male Infertility for Epidemiologists" NIH Symposium on Andrology, Rockville, MD, Aug 25 

Local/Regional

 

2017 

Male Infertility for the IVF RN. Presented at Reproductive Medical Associates of New Jersey, Basking Ridge, NJ, March 7. 

2017 

Male Factor Infertility: Where Do We Go From Here. Utah Infertility Conference, Sandy, Utah, Oct. 7. 

Grand Rounds Presentations

2014 - 2015 

Presenter. Hypogonadism. University of Utah Urology Grand Round, Salt Lake City, Utah 

2014 - Present 

Presenter. Fertility Overview. University of Utah Urology Grand Rounds, Salt Lake City, Utah 

2015 

Presenter. Men's Health for the Patient and the Provider. Grand Rounds, Elko Nevada Regional Health Center, Elko, NV 

2017 

"Male Factor Infertility In The Setting of IVF Failure: Diagnosis & Treatment at Reproductive Medicine Associates of New Jersey, Basking Ridge, NJ, Sept 5 

2017 

Presenter. The Other half: Male Infertility & The Sins of our Fathers. Grand Rounds OBGYN. University of Utah, Salt Lake City, Utah 

2018 

Presenter. Erectile Dysfunction Management. University of Utah Urology Grand Round, Salt Lake City, Utah 

2018 

Presenter. Male Infertility: A Window Into Men’s Health. Grand Rounds, Lakeview Hospital, Salt Lake City, Utah. 

Outreach Presentations

2013 

Presenter, Utah Fertility Center, Men's Health for the Patient and the Provider. 

2013 

Presenter, Granger Medical West Jordan, Men's Health for the Patient and the Provider. 

2013 

Presenter, Riverton Hospital, Men's Health for the Patient and the Provider. 

2014 

Presenter, Utah Valley University, Student Health Center, "5 Myths of Male Infertility" 

2014 

Presenter, Utah Infertility Awareness, Men's Health for the Patient and the Provider. 

2014 

Presenter, South Valley Women's Health Care, Men's Health for the Patient and the Provider. 

2014 

Presenter, Villas at Jordan Landing, Men's Health for the Patient and the Provider. 

2014 

Presenter, St. Mark's Hospital, Men's Health for the Patient and the Provider. 

2014 

Presenter, Jordan Meadows Medical Center, Men's Health for the Patient and the Provider. 

2014 

Presenter, Wade Family Medicine, Men's Health for the Patient and the Provider. 

2014 

Presenter, Lakeview Hospital, Lakeview OB/GYN 

2014 

Presenter, Intermountain Medical Center, Intermountain OB/GYN Outreach 

2014 

Presenter, Salt Lake Regional Medical Center, Men's Health for the Patient and the Provider. 

2014 

Presenter, Cottonwood Hospital, Cottonwood OB/GYN Outreach Talk 

2014 

Presenter, University of Utah Health Care, Marketing and Outreach for Male Infertility 

2014 

Presenter, Central Utah Clinic, Central Utah Clinic Women's center Outreach Talk 

2015 

Presenter, Utah Department of Health, Erectile dysfunction in diabetes 

2015 

Presenter, Reproductive Care Center, Utah Infertility Journal Club Outreach Talk 

2015 

Presenter, Rocky Mountain Women's Health Center, Men's Health for the Patient and the Provider. 

2015 

Presenter, Tanner Clinic, Men's Health for the Patient and the Provider. 

2015 

Presenter, Brigham Young University, Student Health Center, "5 Myths of Male Infertility" 

2015 

Presenter, University of Utah Health Care, Men's Health for the Patient and the Provider. 

2018 

Presenter, University Health Care System, Erectile Dysfunction Causes and Treatments 

OTHER SCHOLARLY ACTIVITIES 

Other Scholarly Activities

2012 - Present 

Andro360, Salt Lake City, Utah. Co-founder of a medical device company making a non-invasive wearable ring to monitor penile erectile function. Company has one issued patent, has been through multiple incubators and is raising a SEED round as well as moving forward with a clinical trial. 
 

2013 - Present 

StreamDx Inc. 
 Established (co-founder) a start up company that resulted from work in the bioinnovate project from 2013-2014. The company, StreamDx, now has 2 patents, 4 full time employees, has raised over $700,000 in capital and will likely have an FDA approved novel uroflow meter for clinical and home use on the market by the end of 2018. StreamDx awarded second place for 2015 Utah Life Sciences company of the year by the Utah innovation Awards and received a SBIR Phase II $1.7M grant in 2017 

2016 - Present 

NANONC Inc., Salt Lake City, Utah. Co-founder of a microfluidic sperm sorting company with Bruce Gale, Doug Carrell, Tim Jenkins, Ki Aston and Raheel Samuel. Company has received a SSTR grant, had a funded SBIR grant that was declined due to overlap with SSTR grant and has one full time and four part time employees. We have two pending patents and received a Fast Track Phase I/II NIH SBIR funding at $1.6M in 2017. 

Peter Humaidan
Peter Humaidan

Professor Peter Humaidan
 is a specialist in reproductive endocrinology, professor at The Fertility Clinic Skive Regional Hospital, Aarhus University, Denmark and Honorary professor at Odense University, Denmark. During his scientific work he has primarily focused on developing individualized treatment protocols for the infertile patient. His doctoral thesis (DMSc) explored the role of LH during the follicular and luteal phases in controlled ovarian stimulation. His main fields of interest are triggering of ovulation with GnRH agonist, role of LH during the follicular and luteal phases, role of the female genital tract microbiota for reproductive outcomes, OHSS prevention, and role of sperm DNA fragmentation for spontaneous and assisted reproduction. He is the founder of the international society “The Copenhagen GnRHa Triggering Workshop Group” who introduced the GnRHa trigger in modern IVF, changing trigger policies worldwide. Moreover, he is co-founder of the POSEIDON group which suggested a new stratification of the poor responder patient. Finally, he is past board member of the ESHRE SIG Endocrinology Group. He authored and co-authored 230 + articles (H-index 60, Google Scholar) in international peer reviewed journals as well as the Danish guidelines for OHSS prevention, and chapters in textbooks. Peter Humaidan has a wide international scientific network and is frequently invited as a speaker at international conferences. 

Juan Carlos Izpisua

Chaim Jalas

Jackson Kirkman-Brown

Csilla Krausz

Elena Labarta
Elena Labarta, M.D., Ph.D., Biography 

Current Job 

Dr. Elena Labarta. MD, Ph.D, is an attending physician at Valencian Institute of Infertility (IVI), Valencia, Spain, where she serves as a specialist in Human Reproduction and Assisted Reproductive Techniques, and as a surgeon specialized in Endoscopic surgery since 2005.  Since 2008, she is associate professor and medical coordinator of several Master related to Human Assisted Reproduction by the University of Valencia.  

Education and Training 
MD The University of Zaragoza 2000
Residency OBGYN The Autonomous University of Madrid 2005
Master (first cycle) in Research on Health Sciences The Autonomous University of Barcelona 2008
Master in Advanced Gynaecological Endoscopic Surgery The University of Valencia 2009
Doctoral Degree (Ph.D) The University of Valencia 2014
Master Level in Reproductive Endoscopic Surgery The European Academy of Gynaecological Surgery and ESGE (GESEA Programme) 2017
 
Research activity
Dr. Labarta has participated in several clinical research projects and has contributed to over 25 publications on assisted reproduction in peer reviewed international journal and written more than 45 book chapters. She is an international speaker. Dr. Labarta was awarded a Doctor Cum Laude in Medicine, University of Valencia in 2014, the title of her thesis being “Influence of Ovarian stimulation during in vitro fertilization treatment on the incidence of embryo aneuploidies”. Dr Labarta´s research is now focused on the predictive value of luteal serum progesterone levels in ART; Ovarian Stimulation and Embryo Quality; Uterine Evaluation and treatment in infertile patients, and the impact of autologous mitochondrial transfer on Oocyte and Embryo Quality in IVF Patients, among others.Honors and Recognition
  1. As a co-author, she received the Scientific Program Prize Paper Award at the 2008 Annual Meeting of the American Society for Reproductive Medicine (ASRM).
  2. Golden Medal “Foro Europa 2001”, for her professional career. 2015, Madrid.

Nicholas Macklon
Nick Macklon 

Current Job
  • Medical Director, London Womens Clinic, London UK
  • Profoessor of Obstetrics and Gynaecology, Zealand University Hospital, University of Copenhagen, Denmark
   Education & Training
  • Specialist training in Edinburgh
  • Doctoral thesis research Glasgow
  • Senior Lecturer, Erasmus Medical Centre Rotterdam
  • Professor, Utrecht Medical Centre 2005-2009
  • Professor, UNiversity of Southampton, 2009-2017
  Research Activity
  • Endometrial- embryo signalling
  • Recurrent implantation failure
  • Periconceptional determinants of fertility and health
  Honors & Recognitions
  • Florey Prize Lecture, University of Adelaide
  • Diksfaluzy Prize Lecture, Karolinska Institute
  • John Collins Prize Lecture, Canadian Andrology and Fertility Society

Svetlana Madjunkova

Ángel Martín

Marcos Meseguer

SHORT BIO

Dr. Marcos Meseguer received his Biological Sciences Degree from the University of Valencia in Spain. He performed a pre-doctoral fellowship in St Mary´s Hospital, Manchester University, United Kingdom.  He received his Ph.D. Degree in Obstetrics and Gynecoloy and the European Doctor Degree in 2002 from the University of Valencia, Spain. He has also a master degree in Research Methods; Design and Statistics from Universidad Autónoma de Barcelona, Spain.

Actually is Scientific Supervisor and Senior Embriologist in the IVF unit of IVIRMA Valencia.  Dr. Meseguer has received and nominated twice the prize paper of the American Society of Reproductive Medicine (ASRM), Four times the Star Award from ASRM. Three times the Lalor Foundation International Award from the American Society of Andrology, three times the research award from the Spanish Society of Fertility and 5 times the research award from the Spanish Society of Embriology.  He received the Robert Edwards prize paper award from RBM on line and was ASRM star award winner. The primary areas of his research are embryology and male infertility.

As Principal Investigator, his work has been funded through 25 projects sponsored by the Spanish Government, including 10 EUREKA. Horizon 2020 EUROSTAR projects (granted to high quality technological projects) supported by the European Community). He has two international patents. 

He is part of the group of researchers most cited in the world according to Standford University has published over 175 scientific articles, with 9135 citations and h-index of 53, including the most cited paper in Human Reproduction. Additionally published 70 reviews or book chapters, edited the first time-lapse book and made more than 700 presentations at national and international congresses. He has been the Director of 16 Doctoral Thesis all qualified with "Cum Laude", and actually is directing 7 PhD candidates.

He is also Statistics Advisor of Equipo IVI and Associate Professor of the Master in Biotechnology from Valencia University.

Scott Morin

Craig Niederberger
Craig Niederberger

Dr. Craig Niederberger is Clarence C. Saelhof Professor and Head of the Department of Urology in the College of Medicine at the University of Illinois at Chicago, and holds a joint appointment as Professor in the Department of Bioengineering in the College of Engineering.  He is Co-Editor in Chief of Fertility and Sterility and a prior section editor for the Journal of Urology.  He is a primary editor of the fourth edition of Infertility in the Male and An Introduction to Male Reproductive Medicine.  He served as general program chair for the American Society for Reproductive Medicine's annual meeting in Atlanta in 2009 and has served as president of the Society for the Study of Male Reproduction within the American Urological Association and as president of the Society for Male Reproduction and Urology within the American Society for Reproductive Medicine.

Jesse Ory

Alberto Pacheco
Alberto Pacheco

Breve curriculum vitae A Pacheco
Doctor en Biología por la Universidad Complutense de Madrid desde 1997. Es director del Laboratorio de Andrología y Banco de semen de la clínica IVI  Madrid desde el año 2002, participando activamente en  distintas líneas de Investigación de Ginecología y Andrología. Ha sido además coordinador, desde su fundación, del Grupo de Interés de Andrologia (GIA) de ASEBIR en los últimos 4 años.
Asimismo, es profesor asociado, y coordinador del área de  Inmunología de la Universidad Alfonso X "El Sabio" de Madrid. Investigador en el área de Inmunología, especialmente en el campo de la inmunología celular e Inmunología de la reproducción.    

Richard Paulson

Richard J. Paulson, MD, MS

Dr. Richard Paulson holds the Alia Tutor Chair in Reproductive Medicine and is Professor and vice-chair in the Department of Obstetrics and Gynecology. He is Chief of the Division and Director of the Fellowship in Reproductive Endocrinology and Infertility. Dr. Paulson received his BS degree in Physics and MD degree from UCLA. He completed residency in Obstetrics & Gynecology at Harbor-UCLA Medical Center and fellowship in Reproductive Endocrinology and Infertility at LA County-USC medical center. He returned to graduate study six years later and obtained an MS degree in Biostatistics and Study Design from USC.

Dr. Paulson is past president of the American Society for Reproductive Medicine, of the Pacific Coast Reproductive Society, the Society for Reproductive Endocrinology and Infertility and the Los Angeles Obstetrical and Gynecological Society. He is the Editor-in-Chief of “Fertility & Sterility Reports” and past deputy editor of “Fertility and Sterility.” Dr. Paulson has authored over 200 scientific articles and has received more than 35 research awards for scientific publications.

Nuria Pellicer

Nuria Pellicer

Dr. Pellicer has participated as a researcher in several clinical research projects, including phase II and phase III clinical trials. She has given more than 25 national and international lectures and has published more than 20 scientific articles and 6 book chapters. Her current research areas are based on ovarian rejuvenation with autologous stem cells and platelet-rich plasma, in patients with low ovarian reserve and premature ovarian insuficiency, compression of the origin of preeclampsia in assisted reproduction treatments, analysis of the effect of expression of proteins in patients with PCOS. She completed her Doctorate in Medicine in 2020, receiving the recognition of CUM LAUDE. She is also one of the coordinators of 4 different masters: Master Oficial en Biotecnología de la Reproducción Human Asistida, Master Degree in the Biotechnology of Human Assisted Reproduction and Embryology, Máster de Formación Permanente Bases Teóricas y Procedimientos de Laboratorio en la Reproducción Asistida, Máster de Formación Permanente en Reproducción Human.

Alexandar Rajkovic

Laura Rienzi
Prof. Laura Rienzi

Adjunct Professor of Biotechnology in Assisted Reproduction, University of Urbino, Italy Director of the Scientific Executive Committee of GeneraLife and co-founder of Genera Senior Clinical Embryologist

With 30 years’ experience in human assisted reproduction technologies, pre-implantation genetic testing and cryopreservation of human oocytes, sperm and embryos, Laura Rienzi is the Director of the Scientific Executive Committee of the GeneraLife network of IVF clinics in Europe.

Laura obtained her degree in Biology magna cum laude at the University of Rome “La Sapienza", University of Rome, a Master degree and a course specialization in Reproductive Medicine at the University of Padua. Since 2016, she is Adjunct Professor of Biotechnology in Assisted Reproduction at the Faculty of Biology, University of Urbino, Italy. She has authored >200 articles (Scopus Index 52), reviews and book chapters, she has also been invited to speak in more than 300 national and international scientific meetings and has won several awards regarding fertility investigation and innovation.

In 2008 she founded together with Dr. Filippo Maria Ubaldi the Genera IVF centers, with 4 different locations in Italy, where she is Laboratory Director. In 2020, she was actively involved in the creation of GeneraLife, a network of >30 clinics in 5 different countries in Europe: the name GeneraLife was inspired by the group she founded 12 years before.

Dennys Sakkas
Denny Sakkas

Dr. Denny Sakkas received his undergraduate training at the University of Melbourne, Australia and received his Doctorate of Philosophy at Monash University, Melbourne, Australia. His Ph. D. was performed at one of the leading Reproductive Research Units in the world.Dr. Sakkas has been the Laboratory Director of IVF units in Switzerland, England and the USA. He has aided numerous groups in establishing their own IVF units around the world. He has extensive experience in clinical IVF and reproductive research. He is internationally recognized, having organized conferences and workshops on reproduction related topics, and is frequently invited as a speaker at major conferences worldwide. He has published more than 150 peer reviewed manuscripts and chapters in the field of fertilization, early embryo development and male infertility. He has been extensively funded in his career and has led productive basic research groups investigating many aspects of gamete and embryo biology.He also served as Chief Scientific Officer of Molecular Biometrics Inc. and was part of a team raising venture capital funding to develop a novel platform to non-invasively assess embryo viability. Dr Sakkas is currently Scientific Director at Boston IVF and remains as an Associate Professor at the Department of Obstetrics, Gynecology and Reproductive Sciences at the Yale University School of Medicine. 

Emre Seli

Emre Seli, MD, is Professor of Obstetrics, Gynecology, and Reproductive Sciences and Medical Director of Yale Reproductive Endocrinology and Infertility Division. He is also the Research Director of IVI-RMA USA and the Chief Scientific Officer of March of Dimes. Dr. Seli received his medical degree from the University of Istanbul and completed his Residency in Obstetrics and Gynecology at Yale University. His postdoctoral training included a fellowship in Reproductive Endocrinology and Infertility as well as a research fellowship in molecular biology, both at Yale University. His laboratory characterized the mechanisms regulating translational activation of gene expression in the oocyte. Dr. Seli and his colleagues also made seminal contributions to our understanding of oocyte and embryo senescence and competence. Dr. Seli is the recipient of many National Institutes of Health (NIH) and pharmaceutical industry-sponsored research grants. He has trained more than 100 pre- and post-doctoral fellows, and published more than 150 scientific articles. In addition, he edited five books including the 9th edition of “Speroff’s Clinical Gynecologic Endocrinology and Infertility“. Dr. Seli is the recipient of the “Ira and Ester Rosenwaks New Investigator Award” from the American Society for Reproductive Medicine (ASRM), and the “President’s Achievement Award” from the Society for Reproductive Investigation (SRI). In addition his work has been shortlisted for nineteen major conference prizes (ASRM and SRI), winning sixteen. He currently serves on the boards of several international journals and professional societies.

Jason Swain
Jason Swain
  • Current Job:  Chief Lab Officer, President of Laboratory Operations, CCRM Fertility
  • Education & Training :  BS- Hillsdale College, MS – Purdue University, PhD- University of Michigan
  • Research Activity:  Improvement of preimplantation embryo culture and ART outcomes through modifications of the chemical and physical environment and via use of new technologies

Filippo Ubaldi
Filippo Maria Ubaldi 

Filippo Maria Ubaldi is the Scienfic Director of GeneraLife, International Reproductive Medicine network (more than 30 Centres in Italy, Spain, Sweden and Czech Republic).

With academic degrees in Ob & Gyn, Masters in Andrology and Reproductive Medicine, PhD in Andrology at the Vrije Universiteit Brussel, he is also intensely dedicated to scientific activity.

Author and co-author of 205 scientific papers with Scopus H-index of 53, he has been invited as speaker at > 600 National and International congresses on the topic of Reproductive Medicine. Member of the ESHRE Executive Committee during 2005-2009, he has been Chairman of the 26th ESHRE Annual Meeting held in Rome in June 2010.

In 2014 and 2019 he received the Italian National Scientific License as full Professor in Obstetrics and Gynaecology and at the present is the Chairman of the Italian Society of Fertility and Sterility (SIFES).

For further information link to:
http://www.generaroma.it/equipe/direzione-clinica-dott-filippo-maria-ubaldi/

Antonio Urda

Frauke Von Versen-Höynck
Prof. Dr. med. Frauke von Versen-Höynck Current Job
  • Associate Professor of Ob/Gyn, Division of Gynecologic Endocrinology and Reproductive Medicine, Hannover Medical School, Germany
  • Head of Research Group Molecular Perinatology
 Education & Training
  • MD from Humboldt University, Berlin, Germany in 2001
  • Doctoral degree (Dr. med.), Humboldt University, Berlin, 2003
  • Residency in Ob/Gyn at the University Hospitals in Aachen (2001-2005) and Hannover (2009-2012), Germany
  • Postdoctoral Fellowship at University of Pittsburgh, USA working on preeclampsia pathophysiology (2005-2009)
  • MSc in Clinical Research from University of Pittsburgh, USA, 2009
  • Habilitation (2nd, doctoral degree/PhD), Hannover Medical School, 2010
  • Fellowship in Gynecologic Endocrinology and Reproductive Medicine at Hannover Medical School, 2012-2014
  • Visiting Associate Professor at Stanford University (2014-2018) working on preeclampsia risk and pregnancy outcomes after infertility
Research Activity
  • Established research group Molecular Perinatology at Hannover Medical School with focus on pregnancy complication preeclampsia
  • Research interest in impact of assisted reproduction on maternal and offspring health
Honors & Recognitions
2003     Research Award, Niederrheinisch-Westfälische Gesellschaft für Gynäkologie und Geburtshilfe2004       Young Investigators Research Award, RWTH Aachen University2005       Research Fellowship Award, RWTH Aachen University2006     Scios Travel Award, North American Society for the Study of Hypertension in Pregnancy2006        Irene McLenahan Young Investigator’s Research Fund Award, University of Pittsburgh2007     Paul M. Rike, M.D., Fellowship Award, Magee Womens Research Institute and Foundation2008       Research Fellowship Award, German Research Foundation2013       Presentation Award of the Northern German Association of Obstetrics and Gynecology2013       Poster Award of the Northern German Association of Obstetrics and Gynecology2013     Presentation Award of the German Association for Pregnancy Hypertension and Preeclampsia2015       Heisenberg Fellowship Award of the German Research Foundation Prof. Frauke von Versen-Höynck, MSc is an Associate Prof. and physician-scientist board-certified in Germany in Obstetrics & Gynecology with a sub-specialization and board-certification in Gynecologic Endocrinology and Reproductive Medicine. She graduated from Humboldt University in Berlin as a M.D. in 2001 and obtained her doctoral degree in fetal membrane research in 2003.She started her residency training in Ob/Gyn at the University hospital in Aachen. During a postdoctoral fellowship at the University of Pittsburgh she was heavily involved in preeclampsia research and afterwards established a research group with focus on preeclampsia pathophysiology in Hannover, Germany. Projects examine the role of vitamin D and the effect of hypoxic conditions on placental development. Another focus is on the role of endothelial progenitor cells (EPCs) in pregnancy and pregnancy complications. She finished residency and a fellowship in Gynecologic Endocrinology and Reproductive Medicine at Hannover Medical School in 2014. Recently, as a Visiting Associate Prof. she was involved in a collaborative project at Stanford University, USA looking at the impact of corpus luteum number at conception on pregnancy outcome, preeclampsia risk and maternal vascular health for which she was awarded a prestigious Heisenberg-Fellowship by the German Research Foundation.

Dagan Wells
Dagan Wells

Professor Dagan Wells has been involved in the diagnosis of inherited disorders in human embryos (preimplantation genetic testing - PGT) and research into the earliest stages of development for almost three decades. He spent several years at University College London, where he accomplished the first comprehensive chromosome analysis of cells from human embryos. This work revealed the remarkable spectrum of cytogenetic abnormalities that exist during the first few days of life and received the ASRM General Program Prize in 1999. Dagan later joined the faculty of Yale University and also served as a Laboratory Director for Reprogenetics, at the time the largest provider of PGT services in the world, establishing its monogenic PGT program. Dagan now serves as Director of Juno Genetics, a state-of-the-art clinical diagnostics laboratory based in Oxford (UK), offering PGT, non-invasive prenatal testing and other genetic tests related to infertility and pregnancy. Dagan also continues to teach and direct research at the University of Oxford where he is a Professor within the Nuffield Department of Women’s and Reproductive Health. Dagan’s work has frequently been noted for its innovation and has led to the publication of over 200 scientific papers. In the last decade his work has been shortlisted for eighteen major conference prizes (ASRM and ESHRE), winning ten. Dagan has been elected to fellowship of the Royal College of Pathologists, the Royal Society of Biology, the Royal College of Obstetricians and Gynaecologists and the Institute of Biomedical Science. He currently serves on the Boards of several international journals and professional societies.  

Important Dates


  • ABSTRACTS
    Abstract Submission form will end on
    February, 20th 2023
  • REGISTRATIONS
    Early Bird Registration until 
    February 21st, 2023

renfe
The organization of the congress has agreed with RENFE (the national Railway Company) a 5% discount for the train tickets for national round trips for all participants. The discount will be available between April 18th – April 24th (both inclusive). In order to obtain the discount you need to be registered to the Congress.

To request it please just send an email to Esta dirección de correo electrónico está siendo protegida contra los robots de spam. Necesita tener JavaScript habilitado para poder verlo.